Cover Page
Cover Page - shares | 9 Months Ended | |
Sep. 30, 2021 | Nov. 01, 2021 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Sep. 30, 2021 | |
Document Transition Report | false | |
Entity File Number | 0-17077 | |
Entity Registrant Name | PENNS WOODS BANCORP INC | |
Entity Incorporation, State or Country Code | PA | |
Entity Address, Address Line One | 300 Market Street, P.O. Box 967 | |
Entity Tax Identification Number | 23-2226454 | |
Entity Address, City or Town | Williamsport | |
Entity Address, State or Province | PA | |
Postal Zip Code | 17703-0967 | |
City Area Code | 570 | |
Local Phone Number | 322-1111 | |
Title of 12(b) Security | Common stock, $5.55 par value | |
Trading Symbol | PWOD | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Other Identification Type | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Smaller Reporting Company | true | |
Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding (in shares) | 7,069,518 | |
Entity Central Index Key | 0000716605 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2021 | |
Document Fiscal Period Focus | Q3 |
CONSOLIDATED BALANCE SHEET (UNA
CONSOLIDATED BALANCE SHEET (UNAUDITED) - USD ($) $ in Thousands | Sep. 30, 2021 | Dec. 31, 2020 |
ASSETS: | ||
Noninterest-bearing balances | $ 35,523 | $ 31,821 |
Interest-bearing balances in other financial institutions | 206,124 | 181,537 |
Federal funds sold | 40,000 | 0 |
Total cash and cash equivalents | 281,647 | 213,358 |
Investment debt securities, available for sale, at fair value | 166,760 | 162,261 |
Investment equity securities, at fair value | 1,263 | 1,288 |
Investment securities, trading | 40 | 40 |
Restricted investment in bank stock, at fair value | 14,649 | 15,377 |
Loans held for sale | 3,246 | 5,239 |
Loans | 1,347,225 | 1,344,327 |
Allowance for loan losses | (14,557) | (13,803) |
Loans, net | 1,332,668 | 1,330,524 |
Premises and equipment, net | 34,434 | 32,702 |
Accrued interest receivable | 8,529 | 8,394 |
Bank-owned life insurance | 33,836 | 33,638 |
Investment in limited partnerships | 5,014 | 3,944 |
Goodwill | 17,104 | 17,104 |
Intangibles | 524 | 671 |
Operating lease right-of-use asset | 2,899 | 3,136 |
Deferred tax asset | 4,049 | 2,526 |
Other assets | 4,129 | 4,441 |
TOTAL ASSETS | 1,910,791 | 1,834,643 |
LIABILITIES: | ||
Interest-bearing deposits | 1,111,144 | 1,045,086 |
Noninterest-bearing deposits | 481,875 | 449,357 |
Total deposits | 1,593,019 | 1,494,443 |
Short-term borrowings | 9,404 | 5,244 |
Long-term borrowings | 126,007 | 153,475 |
Accrued interest payable | 828 | 1,112 |
Operating lease liability | 2,947 | 3,175 |
Other liabilities | 10,105 | 13,048 |
TOTAL LIABILITIES | 1,742,310 | 1,670,497 |
SHAREHOLDERS’ EQUITY: | ||
Preferred stock, no par value, 3,000,000 shares authorized; no shares issued | 0 | 0 |
Common stock, par value 5.55, 22,500,000 shares authorized; 7,545,922 and 7,532,576 shares issued; 7,065,697 and 7,052,351 outstanding | 41,921 | 41,847 |
Additional paid-in capital | 53,508 | 52,523 |
Retained earnings | 87,146 | 82,769 |
Accumulated other comprehensive loss: | ||
Net unrealized gain on available for sale securities | 3,504 | 4,714 |
Defined benefit plan | (5,486) | (5,596) |
Treasury stock at cost, 480,225 | (12,115) | (12,115) |
TOTAL PENNS WOODS BANCORP, INC. SHAREHOLDERS' EQUITY | 168,478 | 164,142 |
Non-controlling interest | 3 | 4 |
TOTAL SHAREHOLDERS' EQUITY | 168,481 | 164,146 |
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ 1,910,791 | $ 1,834,643 |
CONSOLIDATED BALANCE SHEET (U_2
CONSOLIDATED BALANCE SHEET (UNAUDITED) (Parenthetical) - $ / shares | Sep. 30, 2021 | Dec. 31, 2020 |
Statement of Financial Position [Abstract] | ||
Preferred stock, shares authorized (in shares) | 3,000,000 | 3,000,000 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 5.55 | $ 5.55 |
Common stock, shares authorized (in shares) | 22,500,000 | 22,500,000 |
Common stock, shares issued (in shares) | 7,545,922 | 7,532,576 |
Common stock, shares outstanding (in shares) | 7,065,697 | 7,052,351 |
Treasury stock (in shares) | 480,225 | 480,225 |
CONSOLIDATED STATEMENT OF INCOM
CONSOLIDATED STATEMENT OF INCOME (UNAUDITED) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
INTEREST AND DIVIDEND INCOME: | ||||
Loans, including fees | $ 13,382 | $ 14,080 | $ 39,826 | $ 43,403 |
Investment securities: | ||||
Taxable | 834 | 925 | 2,491 | 2,958 |
Tax-exempt | 160 | 170 | 495 | 484 |
Dividend and other interest income | 338 | 212 | 903 | 747 |
TOTAL INTEREST AND DIVIDEND INCOME | 14,714 | 15,387 | 43,715 | 47,592 |
INTEREST EXPENSE: | ||||
Deposits | 1,308 | 2,569 | 4,481 | 8,406 |
Short-term borrowings | 3 | 8 | 7 | 37 |
Long-term borrowings | 771 | 965 | 2,430 | 2,893 |
TOTAL INTEREST EXPENSE | 2,082 | 3,542 | 6,918 | 11,336 |
NET INTEREST INCOME | 12,632 | 11,845 | 36,797 | 36,256 |
PROVISION FOR LOAN LOSSES | 75 | 645 | 940 | 2,040 |
NET INTEREST INCOME AFTER PROVISION FOR LOAN LOSSES | 12,557 | 11,200 | 35,857 | 34,216 |
NON-INTEREST INCOME: | ||||
Net debt securities gains, available for sale | 48 | 1,013 | 323 | 1,220 |
Net equity securities (losses) gains | (6) | 0 | (25) | 30 |
Net securities (losses) gains, trading | (2) | (2) | 1 | (16) |
Bank-owned life insurance | 279 | 156 | 614 | 492 |
Gain on sale of loans | 456 | 1,449 | 2,034 | 2,921 |
Other | 966 | 354 | 2,044 | 1,162 |
TOTAL NON-INTEREST INCOME | 2,951 | 4,035 | 8,474 | 9,093 |
NON-INTEREST EXPENSE: | ||||
Salaries and employee benefits | 5,837 | 5,465 | 17,107 | 16,362 |
Occupancy | 745 | 599 | 2,438 | 1,927 |
Furniture and equipment | 883 | 837 | 2,663 | 2,525 |
Software amortization | 226 | 257 | 632 | 743 |
Pennsylvania shares tax | 373 | 340 | 1,097 | 948 |
Professional fees | 615 | 608 | 1,882 | 1,888 |
Federal Deposit Insurance Corporation deposit insurance | 220 | 271 | 705 | 650 |
Marketing | 231 | 61 | 434 | 170 |
Intangible amortization | 44 | 53 | 147 | 174 |
Other | 1,273 | 1,216 | 3,541 | 4,041 |
TOTAL NON-INTEREST EXPENSE | 10,447 | 9,707 | 30,646 | 29,428 |
INCOME BEFORE INCOME TAX PROVISION | 5,061 | 5,528 | 13,685 | 13,881 |
INCOME TAX PROVISION | 932 | 1,051 | 2,516 | 2,563 |
CONSOLIDATED NET INCOME | 4,129 | 4,477 | 11,169 | 11,318 |
Less: Net income attributable to noncontrolling interest | 4 | 5 | 15 | 13 |
NET INCOME ATTRIBUTABLE TO PENNS WOODS BANCORP, INC. | $ 4,125 | $ 4,472 | $ 11,154 | $ 11,305 |
Earnings per share - basic (in dollars per share) | $ 0.58 | $ 0.63 | $ 1.58 | $ 1.61 |
Earnings per share - diluted (in dollars per share) | $ 0.58 | $ 0.63 | $ 1.58 | $ 1.61 |
Weighted average shares outstanding - basic (in shares) | 7,063,994 | 7,045,336 | 7,059,625 | 7,042,578 |
Weighted average shares outstanding - diluted (in shares) | 7,063,994 | 7,045,336 | 7,059,625 | 7,042,578 |
Dividends declared per share (in dollars per share) | $ 0.32 | $ 0.32 | $ 0.96 | $ 0.96 |
Service charges | ||||
NON-INTEREST INCOME: | ||||
Service charges, insurance commissions, brokerage commissions, and debit card income | $ 456 | $ 388 | $ 1,218 | $ 1,249 |
Insurance commissions | ||||
NON-INTEREST INCOME: | ||||
Service charges, insurance commissions, brokerage commissions, and debit card income | 129 | 101 | 436 | 320 |
Brokerage commissions | ||||
NON-INTEREST INCOME: | ||||
Service charges, insurance commissions, brokerage commissions, and debit card income | 237 | 224 | 663 | 779 |
Debit card income | ||||
NON-INTEREST INCOME: | ||||
Service charges, insurance commissions, brokerage commissions, and debit card income | $ 388 | $ 352 | $ 1,166 | $ 936 |
CONSOLIDATED STATEMENT OF COMPR
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Statement of Comprehensive Income [Abstract] | ||||
Net Income | $ 4,125 | $ 4,472 | $ 11,154 | $ 11,305 |
Other comprehensive income (loss): | ||||
Change in unrealized (loss) gain on available for sale securities | (687) | 1,324 | (1,208) | 3,733 |
Tax effect | 145 | (278) | 254 | (784) |
Net realized gain on available for sale securities included in net income | (48) | (1,013) | (323) | (1,220) |
Tax effect | 9 | 213 | 67 | 256 |
Amortization of unrecognized pension gain | 45 | 52 | 138 | 144 |
Tax effect | (8) | (11) | (28) | (30) |
Total other comprehensive (loss) income | (544) | 287 | (1,100) | 2,099 |
Comprehensive income | $ 3,581 | $ 4,759 | $ 10,054 | $ 13,404 |
CONSOLIDATED STATEMENT OF CHANG
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands | Total | COMMON STOCK | ADDITIONAL PAID-IN CAPITAL | RETAINED EARNINGS | ACCUMULATED OTHER COMPREHENSIVE LOSS | TREASURY STOCK | NON-CONTROLLING INTEREST |
Beginning balance (in shares) at Dec. 31, 2019 | 7,520,740 | ||||||
Beginning balance at Dec. 31, 2019 | $ 154,982 | $ 41,782 | $ 51,487 | $ 76,583 | $ (2,777) | $ (12,115) | $ 22 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net income | 11,318 | 11,305 | 13 | ||||
Other comprehensive loss | 2,099 | 2,099 | |||||
Stock-based compensation | 675 | 675 | |||||
Dividends declared | (6,761) | (6,761) | |||||
Common shares issued for employee stock purchase plan (in shares) | 2,888 | ||||||
Common shares issued for employee stock purchase plan | 64 | $ 16 | 48 | ||||
Director Compensation Plan (in shares) | 3,977 | ||||||
Director Compensation Plan | 80 | $ 22 | 58 | ||||
Distributions to noncontrolling interest | (28) | (28) | |||||
Ending balance (in shares) at Sep. 30, 2020 | 7,527,605 | ||||||
Ending balance at Sep. 30, 2020 | 162,429 | $ 41,820 | 52,268 | 81,127 | (678) | (12,115) | 7 |
Beginning balance (in shares) at Jun. 30, 2020 | 7,522,573 | ||||||
Beginning balance at Jun. 30, 2020 | 159,608 | $ 41,792 | 51,956 | 78,910 | (965) | (12,115) | 30 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net income | 4,477 | 4,472 | 5 | ||||
Other comprehensive loss | 287 | 287 | |||||
Stock-based compensation | 239 | 239 | |||||
Dividends declared | (2,255) | (2,255) | |||||
Common shares issued for employee stock purchase plan (in shares) | 1,055 | ||||||
Common shares issued for employee stock purchase plan | 21 | $ 6 | 15 | ||||
Director Compensation Plan (in shares) | 3,977 | ||||||
Director Compensation Plan | 80 | $ 22 | 58 | ||||
Distributions to noncontrolling interest | (28) | (28) | |||||
Ending balance (in shares) at Sep. 30, 2020 | 7,527,605 | ||||||
Ending balance at Sep. 30, 2020 | 162,429 | $ 41,820 | 52,268 | 81,127 | (678) | (12,115) | 7 |
Beginning balance (in shares) at Dec. 31, 2020 | 7,532,576 | ||||||
Beginning balance at Dec. 31, 2020 | 164,146 | $ 41,847 | 52,523 | 82,769 | (882) | (12,115) | 4 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net income | 11,169 | 11,154 | 15 | ||||
Other comprehensive loss | (1,100) | (1,100) | |||||
Stock-based compensation | 754 | 754 | |||||
Dividends declared | (6,777) | (6,777) | |||||
Common shares issued for employee stock purchase plan (in shares) | 2,873 | ||||||
Common shares issued for employee stock purchase plan | 65 | $ 16 | 49 | ||||
Director Compensation Plan (in shares) | 10,473 | ||||||
Director Compensation Plan | 240 | $ 58 | 182 | ||||
Distributions to noncontrolling interest | (16) | (16) | |||||
Ending balance (in shares) at Sep. 30, 2021 | 7,545,922 | ||||||
Ending balance at Sep. 30, 2021 | 168,481 | $ 41,921 | 53,508 | 87,146 | (1,982) | (12,115) | 3 |
Beginning balance (in shares) at Jun. 30, 2021 | 7,541,627 | ||||||
Beginning balance at Jun. 30, 2021 | 166,835 | $ 41,897 | 53,205 | 85,281 | (1,438) | (12,115) | 5 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net income | 4,129 | 4,125 | 4 | ||||
Other comprehensive loss | (544) | (544) | |||||
Stock-based compensation | 227 | 227 | |||||
Dividends declared | (2,260) | (2,260) | |||||
Common shares issued for employee stock purchase plan (in shares) | 889 | ||||||
Common shares issued for employee stock purchase plan | 20 | $ 5 | 15 | ||||
Director Compensation Plan (in shares) | 3,406 | ||||||
Director Compensation Plan | 80 | $ 19 | 61 | ||||
Distributions to noncontrolling interest | (6) | (6) | |||||
Ending balance (in shares) at Sep. 30, 2021 | 7,545,922 | ||||||
Ending balance at Sep. 30, 2021 | $ 168,481 | $ 41,921 | $ 53,508 | $ 87,146 | $ (1,982) | $ (12,115) | $ 3 |
CONSOLIDATED STATEMENT OF CHA_2
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) (Parenthetical) - $ / shares | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Statement of Stockholders' Equity [Abstract] | ||||
Dividends declared per share (in dollars per share) | $ 0.32 | $ 0.32 | $ 0.96 | $ 0.96 |
CONSOLIDATED STATEMENT OF CASH
CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2021 | Sep. 30, 2020 | |
OPERATING ACTIVITIES: | ||
Net Income | $ 11,169 | $ 11,318 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 2,235 | 2,310 |
Gain on sale of premise and equipment | (18) | (14) |
Amortization of intangible assets | 147 | 174 |
Provision for loan losses | 940 | 2,040 |
Stock based compensation | 754 | 675 |
Accretion and amortization of investment security discounts and premiums | 829 | 382 |
Net securities gains, available for sale | (323) | (1,220) |
Originations of loans held for sale | (68,328) | (95,661) |
Proceeds of loans held for sale | 72,355 | 96,167 |
Gain on sale of loans | (2,034) | (2,921) |
Net equity securities losses (gains) | 25 | (30) |
Net securities (gains) losses, trading | (1) | 16 |
Earnings on bank-owned life insurance | (614) | (492) |
Increase in deferred tax asset | (1,201) | (599) |
Other, net | (3,548) | 2,756 |
Net cash provided by operating activities | 12,387 | 14,901 |
INVESTING ACTIVITIES: | ||
Proceeds from sales of available for sale securities | 13,689 | 37,252 |
Proceeds from calls and maturities of available for sale securities | 15,898 | 567 |
Purchases of available for sale securities | (36,124) | (35,524) |
Net (increase) decrease in loans | (3,167) | 5,692 |
Acquisition of premises and equipment | (939) | (2,830) |
Proceeds from the sale of premises and equipment | 2 | 336 |
Proceeds from the sale of foreclosed assets | 335 | 226 |
Purchase of bank-owned life insurance | (30) | (3,970) |
Proceeds from bank-owned life insurance death benefit | 453 | 248 |
Investment in limited partnership | (1,070) | (628) |
Proceeds from redemption of regulatory stock | 2,167 | 2,881 |
Purchases of regulatory stock | (1,439) | (4,359) |
Net cash used for investing activities | (10,225) | (109) |
FINANCING ACTIVITIES: | ||
Net increase in interest-bearing deposits | 66,058 | 68,303 |
Net increase in noninterest-bearing deposits | 32,518 | 99,502 |
Proceeds from long-term borrowings | 0 | 35,000 |
Repayment of long-term borrowings | (30,000) | (43,333) |
Net increase in short-term borrowings | 4,160 | 10,089 |
Finance lease principal payments | (121) | (53) |
Dividends paid | (6,777) | (6,761) |
Distributions to non-controlling interest | (16) | 0 |
Issuance of common stock | 305 | 144 |
Net cash provided by financing activities | 66,127 | 162,891 |
NET INCREASE IN CASH AND CASH EQUIVALENTS | 68,289 | 177,683 |
CASH AND CASH EQUIVALENTS, BEGINNING | 213,358 | 48,589 |
CASH AND CASH EQUIVALENTS, ENDING | 281,647 | 226,272 |
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: | ||
Interest paid | 7,202 | 11,516 |
Income taxes paid | 3,175 | 2,375 |
Non-cash investing and financing activities: | ||
Right-of-use lease assets obtained in exchange for lessee finance lease liabilities | 2,653 | 0 |
Transfer of loans to foreclosed real estate | $ 83 | $ 207 |
Basis of Presentation
Basis of Presentation | 9 Months Ended |
Sep. 30, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation The consolidated financial statements include the accounts of Penns Woods Bancorp, Inc. (the “Company”) and its wholly-owned subsidiaries: Woods Investment Company, Inc., Woods Real Estate Development Company, Inc., Luzerne Bank, and Jersey Shore State Bank (Jersey Shore State Bank and Luzerne Bank are referred to together as the “Banks”) and Jersey Shore State Bank’s wholly-owned subsidiary, The M Group, Inc. D/B/A The Comprehensive Financial Group (“The M Group”). The Company also owned a controlling interest in United Insurance Solutions, LLC, which on October 15, 2021 became a wholly owned subsidiary of the Company. All significant inter-company balances and transactions have been eliminated in the consolidation. The interim financial statements are unaudited, but in the opinion of management reflect all adjustments necessary for the fair presentation of results for such periods. The results of operations for any interim period are not necessarily indicative of results for the full year. These financial statements should be read in conjunction with the financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. In reference to the attached financial statements, all adjustments are of a normal recurring nature pursuant to Rule 10-01(b) (8) of Regulation S-X. |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Gain (loss) | 9 Months Ended |
Sep. 30, 2021 | |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] | |
Accumulated Other Comprehensive Gain (loss) | Accumulated Other Comprehensive Gain (Loss) The changes in accumulated other comprehensive gain (loss) by component shown net of tax and parenthesis indicating debits, as of September 30, 2021 and 2020 were as follows: Three Months Ended September 30, 2021 Three Months Ended September 30, 2020 (In Thousands) Net Unrealized Gain on Available Defined Total Net Unrealized Defined Total Beginning balance $ 4,085 $ (5,523) $ (1,438) $ 4,194 $ (5,159) $ (965) Other comprehensive (loss) gain before reclassifications (542) — (542) 1,046 — 1,046 Amounts reclassified from accumulated other comprehensive (loss) gain (39) 37 (2) (800) 41 (759) Net current-period other comprehensive (loss) income (581) 37 (544) 246 41 287 Ending balance $ 3,504 $ (5,486) $ (1,982) $ 4,440 $ (5,118) $ (678) Nine Months Ended September 30, 2021 Nine Months Ended September 30, 2020 (In Thousands) Net Unrealized Gain (Loss) on Available for Sale Securities Defined Total Net Unrealized Gain (Loss) on Available Defined Total Beginning balance $ 4,714 $ (5,596) $ (882) $ 2,455 $ (5,232) $ (2,777) Other comprehensive gain (loss) before reclassifications (954) — (954) 2,949 — 2,949 Amounts reclassified from accumulated other comprehensive (loss) gain (256) 110 (146) (964) 114 (850) Net current-period other comprehensive (loss) income (1,210) 110 (1,100) 1,985 114 2,099 Ending balance $ 3,504 $ (5,486) $ (1,982) $ 4,440 $ (5,118) $ (678) The reclassifications out of accumulated other comprehensive loss shown, net of tax and parenthesis indicating debits to net income, as of September 30, 2021 and 2020 were as follows: Details about Accumulated Other Comprehensive Loss Components Amount Reclassified from Accumulated Other Comprehensive Loss Affected Line Item Three Months Ended September 30, 2021 Three Months Ended September 30, 2020 Net unrealized gain on available for sale securities $ 48 $ 1,013 Net debt securities gains, available for sale Income tax effect (9) (213) Income tax provision Total reclassifications for the period $ 39 $ 800 Net unrecognized pension costs $ (46) $ (52) Other non-interest expense Income tax effect 9 11 Income tax provision Total reclassifications for the period $ (37) $ (41) Details about Accumulated Other Comprehensive Loss Components Amount Reclassified from Accumulated Other Comprehensive Loss Affected Line Item Nine months ended September 30, 2021 Nine months ended September 30, 2020 Net unrealized gain on available for sale securities $ 323 $ 1,220 Net debt securities gains, available for sale Income tax effect (67) (256) Income tax provision Total reclassifications for the period $ 256 $ 964 Net unrecognized pension costs $ (139) $ (144) Other non-interest expense Income tax effect 29 30 Income tax provision Total reclassifications for the period $ (110) $ (114) |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 9 Months Ended |
Sep. 30, 2021 | |
Accounting Standards Update and Change in Accounting Principle [Abstract] | |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments , which changes the impairment model for most financial assets. This Update is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The underlying premise of the Update is that financial assets measured at amortized cost should be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. The allowance for credit losses should reflect management’s current estimate of credit losses that are expected to occur over the remaining life of a financial asset. The income statement will be affected for the measurement of credit losses for newly recognized financial assets, as well as the expected increases or decreases of expected credit losses that have taken place during the period. With certain exceptions, transition to the new requirements will be through a cumulative-effect adjustment to opening retained earnings as of the beginning of the first reporting period in which the guidance is adopted. This Update is effective for SEC filers that are eligible to be smaller reporting companies, non-SEC filers, and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We expect to recognize a one-time cumulative-effect adjustment to the allowance for loan losses as of the beginning of the first reporting period in which the new standard is effective but cannot yet determine the magnitude of any such one-time adjustment or the overall impact of the new guidance on the consolidated financial statements. In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment. To simplify the subsequent measurement of goodwill, the FASB eliminated Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under the amendments in this Update, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. The Update is effective for smaller reporting companies and all other entities for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. This Update is not expected to have a significant impact on the Company’s financial statements. In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments – Credit Losses, Derivatives, and Hedging (Topic 815); and Financial Instruments (Topic 825), which affects a variety of topics in the Codification and applies to all reporting entities within the scope of the affected accounting guidance. ASU 2019-04 makes clarifying amendments to certain financial instrument standards. For entities that have not yet adopted ASU 2016-13, the effective dates for the amendments related to ASU 2016-13 are the same as the effective dates in ASU 2016-13. For entities that have adopted ASU 2016-13, the amendments related to ASU 2016-13 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. For entities that have not yet adopted ASU 2017-12 as of April 25, 2019, the effective dates for the amendments to Topic 815 are the same as the effective dates in ASU 2017-12. For entities that have adopted ASU 2017-12 as of April 25, 2019, the effective date is as of the beginning of the first annual period beginning after April 25, 2019. The amendments related to ASU 2016-01 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company qualifies as a smaller reporting company and does not expect to early adopt these ASUs. In May 2019, the FASB issued ASU 2019-05, Financial Instruments – Credit Losses (Topic 326) , which allows entities to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost upon adoption of the new credit losses standard. To be eligible for the transition election, the existing financial asset must otherwise be both within the scope of the new credit losses standard and eligible for applying the fair value option in ASC 825-10.3. The election must be applied on an instrument-by-instrument basis and is not available for either available-for-sale or held-to-maturity debt securities. For entities that elect the fair value option, the difference between the carrying amount and the fair value of the financial asset would be recognized through a cumulative-effect adjustment to opening retained earnings as of the date an entity adopted ASU 2016-13. Changes in fair value of that financial asset would subsequently be reported in current earnings. For entities that have not yet adopted the credit losses standard, the ASU is effective when they implement the credit losses standard. For entities that already have adopted the credit losses standard, the ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company qualifies as a smaller reporting company and does not expect to early adopt ASU 2016-13. In November 2019, the FASB issued ASU 2019-11, Codification Improvements to Topic 326, Financial Instruments – Credit Losses , to clarify its new credit impairment guidance in ASC 326, based on implementation issues raised by stakeholders. This Update clarified, among other things, that expected recoveries are to be included in the allowance for credit losses for these financial assets; an accounting policy election can be made to adjust the effective interest rate for existing troubled debt restructurings based on the prepayment assumptions instead of the prepayment assumptions applicable immediately prior to the restructuring event; and extends the practical expedient to exclude accrued interest receivable from all additional relevant disclosures involving amortized cost basis. For entities that have not yet adopted ASU 2016-13 as of November 26, 2019, the effective dates for ASU 2019-11 are the same as the effective dates and transition requirements in ASU 2016-13. For entities that have adopted ASU 2016-13, ASU 2019-11 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company qualifies as a smaller reporting company and does not expect to early adopt these ASUs. In March 2020, the FASB issued ASU 2020-03, Codification Improvements to Financial Instruments . This ASU was issued to improve and clarify various financial instruments topics, including the current expected credit losses (CECL) standard issued in 2016. The ASU includes seven issues that describe the areas of improvement and the related amendments to GAAP; they are intended to make the standards easier to understand and apply and to eliminate inconsistencies, and they are narrow in scope and are not expected to significantly change practice for most entities. Among its provisions, the ASU clarifies that all entities, other than public business entities that elected the fair value option, are required to provide certain fair value disclosures under ASC 825, Financial Instruments, in both interim and annual financial statements. It also clarifies that the contractual term of a net investment in a lease under Topic 842 should be the contractual term used to measure expected credit losses under Topic 326. Amendments related to ASU 2019-04 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is not permitted before an entity’s adoption of ASU 2016-01. Amendments related to ASU 2016-13 for entities that have not yet adopted that guidance are effective upon adoption of the amendments in ASU 2016-13. Early adoption is not permitted before an entity’s adoption of ASU 2016-13. Amendments related to ASU 2016-13 for entities that have adopted that guidance are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. Other amendments are effective upon issuance of this ASU. The Company is currently evaluating the impact the adoption of the standard will have on the Company’s financial position or results of operations. In January 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, March 2020 , to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as the Secured Overnight Financing Rate. Entities can elect not to apply certain modification accounting requirements to contracts affected by what the guidance calls “reference rate reform” if certain criteria are met. An entity that makes this election would not have to remeasure the contracts at the modification date or reassess a previous accounting determination. Also, entities can elect various optional expedients that would allow them to continue applying hedge accounting for hedging relationships affected by reference rate reform if certain criteria are met, and can make a one-time election to sell and/or reclassify held-to-maturity debt securities that reference an interest rate affected by reference rate reform. The amendments in this ASU are effective for all entities upon issuance through December 31, 2022. It is too early to predict whether a new rate index replacement and the adoption of the ASU will have a material impact on the Company’s financial statements. In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40) , which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. This ASU removes from U.S. GAAP the separation models for (1) convertible debt with a cash conversion feature and (2) convertible instruments with a beneficial conversion feature. As a result, entities will not separately present in equity an embedded conversion feature in such debt. Instead, they will account for a convertible debt instrument wholly as debt, and for convertible preferred stock wholly as preferred stock (i.e., as a single unit of account), unless (1) a convertible instrument contains features that require bifurcation as a derivative under ASC 815 or (2) a convertible debt instrument was issued at a substantial premium. This ASU requires entities to provide expanded disclosures about the terms and features of convertible instruments, how the instruments have been reported in the entity’s financial statements, and information about events, conditions, and circumstances that can affect how to assess the amount or timing of an entity’s future cash flows related to those instruments. The amendments in this ASU are effective for public business entities that are not smaller reporting companies, for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. For all other entities, this ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The guidance may be early adopted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. This Update is not expected to have a significant impact on the Company’s financial statements. In October 2020, the FASB issued ASU 2020-08, Codification Improvements to Subtopic 310-20, Receivables – Nonrefundable Fees and Other Costs, which clarifies that, for each reporting period, an entity should reevaluate whether a callable debt security is within the scope of ASC 310-20-35-33. For public business entities, ASU 2020-08 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is not permitted. For all other entities, ASU 2020-08 is effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. This Update is not expected to have a significant impact on the Company’s financial statements. In October 2020, the FASB issued ASU 2020-09, Debt (Topic 470): Amendments to SEC Paragraphs Pursuant to SEC Release No. 33-10762 , which codifies, as appropriate, the amended financial statement disclosure requirements in Regulation S-X Rules 13-01 and 13-02. The amendments were effective January 4, 2021. This Update did not have a significant impact on the Company’s financial statements. In October 2020, the FASB issued ASU 2020-10, Codification Improvements , which makes minor technical corrections and clarifications to the ASC. The amendments in Sections B and C of the ASU are effective for annual periods beginning after December 15, 2020, for public business entities. For all other entities, the amendments are effective for annual periods beginning after December 15, 2021, and interim periods within annual periods beginning after December 15, 2022. This Update is not expected to have a significant impact on the Company’s financial statements. In November 2020, the FASB issued ASU 2020-11, Financial Services – Insurance (Topic 944) , which was made in consideration of the implications of the Coronavirus Disease 2019 (COVID-19) pandemic on an insurance entity’s ability to effectively implement the amendments in Accounting Standards Update No. 2018-12, Financial Services— Insurance: Targeted Improvements to the Accounting for Long-Duration Contracts (LDTI). The amendments in this Update defer the effective date of LDTI for all entities by one year, as (1) for public business entities that meet the definition of an SEC filer and are not SRCs, LDTI is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years; and (2) for all other entities, LDTI is effective for fiscal years beginning after December 15, 2024, and interim periods within fiscal years beginning after December 15, 2025. This Update is not expected to have a significant impact on the Company’s financial statements. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848) , which provides optional temporary guidance for entities transitioning away from the London Interbank Offered Rate (LIBOR) and other interbank offered rates (IBORs) to new references rates so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions within Topic 848. ASU 2021-01 clarifies that the derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. ASU 2021-01 is effective immediately for all entities. Entities may elect to apply the amendments on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or on a prospective basis to new modifications from any date within an interim period that includes or is subsequent to the date of the issuance of a final update, up to the date that financial statements are available to be issued. The amendments in this update do not apply to contract modifications made, as well as new hedging relationships entered into, after December 31, 2022, and to existing hedging relationships evaluated for effectiveness for periods after December 31, 2022, except for certain hedging relationships existing as of December 31, 2022, that apply certain optional expedients in which the accounting effects are recorded through the end of the hedging relationship. The Company is currently evaluating the impact the adoption of the standard will have on the Company’s financial position or results of operations. In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt – Modifications and Extinguishments (Subtopic 470-50), Compensation – Stock Compensation (Topic 718), and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40), which requires an entity to treat a modification of an equity-classified warrant that does not cause the warrant to become liability-classified as an exchange of the original warrant for a new warrant. This guidance applies whether the modification is structured as an amendment to the terms and conditions of the warrant or as termination of the original warrant and issuance of a new warrant. An entity should measure the effect of a modification as the difference between the fair value of the modified warrant and the fair value of that warrant immediately before modification. The amendments in this Update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. Early adoption is permitted for all entities, including adoption in an interim period. If an entity elects to early adopt the amendments in this Update in an interim period, the guidance should be applied as of the beginning of the fiscal year that includes that interim period. This Update is not expected to have a significant impact on the Company’s financial statements. In July 2021, the FASB issued ASU 2021-05, Leases (Topic 842), which amends ASC 842 so that lessors are no longer required to recognize a selling loss upon commencement of a lease with variable lease payments that, prior to the amendments, would have been classified as a sales-type or direct financing lease. Furthermore, a lessor must classify as an operating lease any lease that would otherwise be classified as a sales-type or direct financing lease and that would result in the recognition of a selling loss at lease commencement, provided that the lease includes variable lease payments that do not depend on an index or rate. For public business entities and certain not-for-profit entities and employee benefit plans that have adopted ASC 842, the amendments are effective for fiscal years beginning after December 15, 2021, and for interim periods within those fiscal years. For all other entities that have adopted ASC 842, the amendments are effective for fiscal years beginning after December 15, 2021, and for interim periods within fiscal years beginning after December 15, 2022. All entities that have adopted ASC 842 are permitted to early adopt the amendments in ASU 2021-05. The amendments in ASU 2021-05 are effective as of the same date as the guidance in ASC 842 for entities that have not adopted ASC 842. This Update is not expected to have a significant impact on the Company’s financial statements. In August 2021, the FASB issued ASU 2021-06, Presentation of Financial Statements (Topic 205), Financial Services – Depository and Lending (Topic 942), and Financial Services – Investment Companies (Topic 946): Amendments to SEC Paragraphs Pursuant to SEC Final Rule Releases No. 33-10786, Amendments to Financial Disclosures about Acquired and Disposed Businesses, and No. 33-10835, Update of Statistical Disclosures for Bank and Savings and Loan Registrants (SEC Update) , to amend SEC paragraphs in the Accounting Standards Codification to reflect the issuance of SEC Release No. 33-10786, Amendments to Financial Disclosures about Acquired and Disposed Businesses , and No. 33-10835, Update of Statistical Disclosures for Bank and Savings and Loan Registrants |
Per Share Data
Per Share Data | 9 Months Ended |
Sep. 30, 2021 | |
Earnings Per Share [Abstract] | |
Per Share Data | Per Share Data There are no convertible securities which would affect the denominator in calculating basic and dilutive earnings per share. There were a total of 1,045,475 stock options, with an average exercise price of $27.25, outstanding on September 30, 2021. These options were excluded, on a weighted average basis, in the computation of diluted earnings per share for the period due to the average market price of common shares of $23.70 being less than the exercise price of the options issued. There were a total of 864,300 stock options, with an average exercise price of $28.20 that were excluded, on a weighted average basis, in the computation of diluted earnings per share for the period due to the average market price of common shares of $24.20 being less than the strike price for the period ending September 30, 2020. Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Weighted average common shares issued 7,544,219 7,525,561 7,539,850 7,522,803 Weighted average treasury stock shares (480,225) (480,225) (480,225) (480,225) Weighted average common shares outstanding - basic and diluted 7,063,994 7,045,336 7,059,625 7,042,578 |
Investment Securities
Investment Securities | 9 Months Ended |
Sep. 30, 2021 | |
Investments, Debt and Equity Securities [Abstract] | |
Investment Securities | Investment Securities The amortized cost, gross unrealized gains and losses, and fair values of our investment securities portfolio at September 30, 2021 and December 31, 2020 are as follows: September 30, 2021 Gross Gross Amortized Unrealized Unrealized Fair (In Thousands) Cost Gains Losses Value Available for sale (AFS): Mortgage-backed securities $ 1,765 $ 10 $ — $ 1,775 State and political securities 112,308 4,610 (444) 116,474 Other debt securities 48,251 727 (467) 48,511 Total debt securities $ 162,324 $ 5,347 $ (911) $ 166,760 Investment equity securities: Other equity securities $ 1,300 $ — $ (37) $ 1,263 Trading: Other equity securities $ 50 $ — $ (10) $ 40 December 31, 2020 Gross Gross Amortized Unrealized Unrealized Fair (In Thousands) Cost Gains Losses Value Available for sale (AFS): Mortgage-backed securities $ 2,118 $ 23 $ — $ 2,141 State and political securities 102,690 5,382 (59) 108,013 Other debt securities 51,486 828 (207) 52,107 Total debt securities $ 156,294 $ 6,233 $ (266) $ 162,261 Investment equity securities: Other equity securities $ 1,300 $ 10 $ (22) $ 1,288 Trading: Other equity securities $ 50 $ — $ (10) $ 40 The following tables show the Company’s gross unrealized losses and fair value, aggregated by investment category and length of time, that the individual debt securities have been in a continuous unrealized loss position, at September 30, 2021 and December 31, 2020. September 30, 2021 Less than Twelve Months Twelve Months or Greater Total Gross Gross Gross Fair Unrealized Fair Unrealized Fair Unrealized (In Thousands) Value Losses Value Losses Value Losses Available for sale (AFS): State and political securities $ 29,367 $ (431) $ 888 $ (13) $ 30,255 $ (444) Other debt securities 10,107 (172) 2,766 (295) 12,873 (467) Total debt securities $ 39,474 $ (603) $ 3,654 $ (308) $ 43,128 $ (911) December 31, 2020 Less than Twelve Months Twelve Months or Greater Total Gross Gross Gross Fair Unrealized Fair Unrealized Fair Unrealized (In Thousands) Value Losses Value Losses Value Losses Available for sale (AFS): State and political securities $ 12,311 $ (51) $ 900 $ (8) $ 13,211 $ (59) Other debt securities 5,964 (74) 4,429 (133) 10,393 (207) Total debt securities $ 18,275 $ (125) $ 5,329 $ (141) $ 23,604 $ (266) At September 30, 2021, there were a total of 71 securities in a continuous unrealized loss position for less than twelve months and 7 individual securities that were in a continuous unrealized loss position for twelve months or greater. The Company reviews its position quarterly and has determined that, at September 30, 2021, the declines outlined in the above table represent temporary declines and the Company does not intend to sell and does not believe it will be required to sell these securities before recovery of their cost basis, which may be at maturity. The Company has concluded that the unrealized losses disclosed above are not other than temporary but are the result of interest rate changes, sector credit ratings changes, or company-specific ratings changes that are not expected to result in the non-collection of principal and interest during the period. The amortized cost and fair value of debt securities at September 30, 2021, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities since borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. (In Thousands) Amortized Cost Fair Value Due in one year or less $ 11,076 $ 10,828 Due after one year to five years 76,785 78,108 Due after five years to ten years 69,469 72,703 Due after ten years 4,994 5,121 Total $ 162,324 $ 166,760 Total gross proceeds from sales of debt securities available for sale for the nine months ended September 30, 2021 was $13,689,000, compared to $37,252,000 for the corresponding 2020 period. The following table represents gross realized gains and losses from the sales of debt securities available for sale: Three Months Ended September 30, Nine Months Ended September 30, (In Thousands) 2021 2020 2021 2020 Available for sale (AFS): Gross realized gains: Mortgage-backed securities $ — $ — $ — $ 83 State and political securities 1 839 1 943 Other debt securities 48 174 323 194 Total gross realized gains $ 49 $ 1,013 $ 324 $ 1,220 Gross realized losses: State and political securities $ 1 $ — $ 1 $ — Other debt securities — — — — Total gross realized losses $ 1 $ — $ 1 $ — There were no impairment charges included in gross realized losses for the three and nine months ended September 30, 2021 and 2020, respectively. Investment securities with a carrying value of approximately $121,299,000 and $111,247,000 at September 30, 2021 and December 31, 2020, respectively, were pledged to secure certain deposits, repurchase agreements, and for other purposes as required by law. At September 30, 2021 and December 31, 2020, we had $1,263,000 and $1,288,000, respectively, in equity securities recorded at fair value. The following is a summary of unrealized and realized gains and losses recognized in net income on equity securities during the three and nine months ended September 30, 2021 and 2020: Three Months Ended September 30, Nine Months Ended September 30, (In Thousands) 2021 2020 2021 2020 Net (losses) gains recognized in equity securities during the period $ (6) $ — $ (25) $ 30 Less: Net gains realized on the sale of equity securities during the period — — — — Unrealized (losses) gains recognized in equity securities held at reporting date $ (6) $ — $ (25) $ 30 Net gains and losses on trading account securities are as follows for the three and nine months ended September 30, 2021 and 2020: Three Months Ended September 30, Nine Months Ended September 30, (In Thousands) 2021 2020 2021 2020 Net gains on sale transactions $ — $ — $ — $ — Net mark-to-market (losses) gains (2) (2) 1 (16) Net (loss) gain on trading account securities $ (2) $ (2) $ 1 $ (16) |
Loans
Loans | 9 Months Ended |
Sep. 30, 2021 | |
Loans and Leases Receivable Disclosure [Abstract] | |
Loans | Loans Management segments the Banks' loan portfolio to a level that enables risk and performance monitoring according to similar risk characteristics. Loans are segmented based on the underlying collateral characteristics. Categories include commercial, financial, and agricultural, real estate, and installment loans. Real estate loans are further segmented into three categories: residential, commercial, and construction, while installment loans are classified as either consumer automobile loans or other installment loans. The following table presents the related aging categories of loans, by segment, as of September 30, 2021 and December 31, 2020: September 30, 2021 Past Due Past Due 90 30 To 89 Days Or More Non- (In Thousands) Current Days & Still Accruing Accrual Total Commercial, financial, and agricultural $ 179,079 $ 147 $ — $ 422 $ 179,648 Real estate mortgage: Residential 584,765 1,709 511 940 587,925 Commercial 371,197 315 — 5,498 377,010 Construction 45,899 — — 49 45,948 Consumer automobile loans 146,094 552 17 — 146,663 Other consumer installment loans 9,363 48 326 — 9,737 1,336,397 $ 2,771 $ 854 $ 6,909 1,346,931 Net deferred loan fees and discounts 294 294 Allowance for loan losses (14,557) (14,557) Loans, net $ 1,322,134 $ 1,332,668 December 31, 2020 Past Due Past Due 90 30 To 89 Days Or More Non- (In Thousands) Current Days & Still Accruing Accrual Total Commercial, financial, and agricultural $ 163,583 $ 247 $ 48 $ 865 $ 164,743 Real estate mortgage: Residential 580,292 6,386 983 2,060 589,721 Commercial 366,363 533 150 6,142 373,188 Construction 38,587 667 — 55 39,309 Consumer automobile loans 155,472 900 31 — 156,403 Other consumer installment loans 19,485 455 — — 19,940 1,323,782 $ 9,188 $ 1,212 $ 9,122 1,343,304 Net deferred loan fees and discounts 1,023 1,023 Allowance for loan losses (13,803) (13,803) Loans, net $ 1,311,002 $ 1,330,524 The following table presents interest income the Banks would have recorded if interest had been recorded based on the original loan agreement terms and rate of interest for non-accrual loans and interest income recognized on a cash basis for non-accrual loans for the three and nine months ended September 30, 2021 and 2020: Three Months Ended September 30, 2021 2020 (In Thousands) Interest Income That Interest Interest Income That Interest Commercial, financial, and agricultural $ 28 $ — $ 2 $ 14 Real estate mortgage: Residential 6 — 14 2 Commercial 89 — 52 — Construction — — — — Consumer automobile loans — — — — Other consumer installment loans — — — — $ 123 $ — $ 68 $ 16 Nine Months Ended September 30, 2021 2020 (In Thousands) Interest Income That Interest Interest Income That Interest Commercial, financial, and agricultural $ 84 $ — $ 37 $ 14 Real estate mortgage: Residential 22 — 27 2 Commercial 144 — 116 — Construction 2 — 1 — Consumer automobile loans — — 2 3 Other consumer installment loans — — 3 — $ 252 $ — $ 186 $ 19 Impaired Loans Impaired loans are loans for which it is probable the Banks will not be able to collect all amounts due according to the contractual terms of the loan agreement. The Banks individually evaluate such loans for impairment and do not aggregate loans by major risk classifications. The definition of “impaired loans” is not the same as the definition of “non-accrual loans,” although the two categories overlap. The Banks may choose to place a loan on non-accrual status due to payment delinquency or uncertain collectability, while not classifying the loan as impaired. Factors considered by management in determining impairment include payment status and collateral value. The amount of impairment for these types of loans is determined by the difference between the present value of the expected cash flows related to the loan, using the original interest rate, and its recorded value, or as a practical expedient in the case of collateralized loans, the difference between the fair value of the collateral and the recorded amount of the loan. When foreclosure is probable, impairment is measured based on the fair value of the collateral. Management evaluates individual loans in all of the commercial segments for possible impairment if the loan is greater than $100,000 and if the loan is either on non-accrual status or has a risk rating of substandard or worse. Management may also elect to measure an individual loan for impairment if less than $100,000 on a case-by-case basis. Mortgage loans on one-to-four family properties and all consumer loans are large groups of smaller-balance homogeneous loans and are measured for impairment collectively with the exception of loans identified as troubled debt restructurings. Loans that experience insignificant payment delays, which are defined as 90 days or less, generally are not classified as impaired. Management determines the significance of payment delays on a case-by-case basis taking into consideration all circumstances surrounding the loan and the borrower including the length of the delay, the borrower’s prior payment record, and the amount of shortfall in relation to the principal and interest owed. Interest income for impaired loans is recorded consistent to the Banks' policy. The following table presents the recorded investment, unpaid principal balance, and related allowance of impaired loans by segment as of September 30, 2021 and December 31, 2020: September 30, 2021 Recorded Unpaid Principal Related (In Thousands) Investment Balance Allowance With no related allowance recorded: Commercial, financial, and agricultural $ 1,265 $ 1,265 $ — Real estate mortgage: Residential 4,003 4,003 — Commercial 3,919 3,919 — Construction 114 114 — Consumer automobile loans — — — Installment loans to individuals — — — 9,301 9,301 — With an allowance recorded: Commercial, financial, and agricultural 420 3,207 2 Real estate mortgage: Residential 1,273 1,273 246 Commercial 6,366 6,366 902 Construction — — — Consumer automobile loans — — — Installment loans to individuals 20 20 20 8,079 10,866 1,170 Total: Commercial, financial, and agricultural 1,685 4,472 2 Real estate mortgage: Residential 5,276 5,276 246 Commercial 10,285 10,285 902 Construction 114 114 — Consumer automobile loans — — — Installment loans to individuals 20 20 20 $ 17,380 $ 20,167 $ 1,170 December 31, 2020 Recorded Unpaid Principal Related (In Thousands) Investment Balance Allowance With no related allowance recorded: Commercial, financial, and agricultural $ 865 $ 3,652 $ — Real estate mortgage: Residential 5,023 5,023 — Commercial 6,354 6,354 — Construction 124 124 — Consumer automobile loans — — — Installment loans to individuals — — — 12,366 15,153 — With an allowance recorded: Commercial, financial, and agricultural — — — Real estate mortgage: Residential 1,294 1,294 224 Commercial 3,023 3,023 811 Construction — — — Consumer automobile loans — — — Installment loans to individuals — — — 4,317 4,317 1,035 Total: Commercial, financial, and agricultural 865 3,652 — Real estate mortgage: Residential 6,317 6,317 224 Commercial 9,377 9,377 811 Construction 124 124 — Consumer automobile loans — — — Installment loans to individuals — — — $ 16,683 $ 19,470 $ 1,035 The following table presents the average recorded investment in impaired loans and related interest income recognized for the three and nine months ended September 30, 2021 and 2020: Three Months Ended September 30, 2021 2020 (In Thousands) Average Interest Income Interest Income Average Interest Income Interest Income Commercial, financial, and agricultural $ 2,052 $ 13 $ — $ 1,543 $ 33 $ 14 Real estate mortgage: Residential 5,218 53 — 5,117 63 2 Commercial 10,530 61 — 6,587 71 — Construction 115 1 — 54 1 — Consumer automobile — — — 147 — — Other consumer installment loans 20 — — — — — $ 17,935 $ 128 $ — $ 13,448 $ 168 $ 16 Nine Months Ended September 30, 2021 2020 (In Thousands) Average Interest Income Interest Income Average Interest Income Interest Income Commercial, financial, and agricultural $ 1,458 $ 43 $ — $ 1,849 $ 34 $ 14 Real estate mortgage: Residential 5,650 151 — 5,535 177 2 Commercial 9,848 126 — 7,577 118 — Construction 119 4 — 60 1 — Consumer automobile 38 — — 111 1 3 Other consumer installment loans 10 9 — 4 — — $ 17,123 $ 333 $ — $ 15,136 $ 331 $ 19 Troubled Debt Restructurings The loan portfolio also includes certain loans that have been modified in a Troubled Debt Restructuring (“TDR”), where economic concessions have been granted to borrowers who have experienced or are expected to experience financial difficulties. These concessions typically result from loss mitigation activities and could include reductions in the interest rate, payment extensions, forgiveness of principal, forbearance, or other actions. Certain TDRs are classified as nonperforming at the time of restructure and may only be returned to performing status after considering the borrower’s sustained repayment performance for a reasonable period, generally six months. There were five loan modifications considered to be TDRs completed during the nine months ended September 30, 2021, respectively. There were no loan modifications considered TDRs completed during the three and nine months ended September 30, 2020. Loan modifications that are considered TDRs completed during the three and nine months ended September 30, 2021 were as follows: Three Months Ended September 30, 2021 (In Thousands, Except Number of Contracts) Number Pre-Modification Outstanding Recorded Investment Post-Modification Outstanding Recorded Investment Commercial, financial, and agricultural — $ — $ — Real estate mortgage: Residential — — — Commercial — — — Construction — — — — $ — $ — Nine Months Ended September 30, 2021 (In Thousands, Except Number of Contracts) Number Pre-Modification Post-Modification Commercial, financial, and agricultural 1 $ 949 $ 949 Real estate mortgage: Residential 2 865 865 Commercial 2 855 855 Construction — — — 5 $ 2,669 $ 2,669 There were two loan modifications considered to be TDRs made during the twelve months prior to September 30, 2021 that defaulted during the nine months ended September 30, 2021. The defaulted loan type and recorded investment at September 30, 2021 are as follows: two residential real estate loan with a recorded investment of $706,000. There were two loan modifications considered to be TDRs made during the twelve months previous to September 30, 2020 that defaulted during the nine months ended September 30, 2020. The defaulted loan types and recorded investments at September 30, 2020 are as follows: one commercial real estate loan with a recorded investment of $1,040,000, and one commercial and agricultural loans with a recorded investment of $640,000. Troubled debt restructurings amounted to $12,612,000 and $12,359,000 as of September 30, 2021 and December 31, 2020, respectively. The amount of foreclosed residential real estate held at September 30, 2021 and December 31, 2020, totaled $83,000 and $401,000, respectively. Consumer mortgage loans secured by residential real estate properties for which formal foreclosure proceedings are in process at September 30, 2021 and December 31, 2020, totaled $193,000 and $629,154, respectively. The Company began offering short-term loan modifications to provide relief to borrowers during the COVID-19 national emergency. The CARES Act along with a joint agency statement issued by federal and state banking agencies, provides that short-term modifications made in a good faith basis in response to COVID-19 who were current at the time the modification program is implemented do not need to be accounted for as TDRs. Loan modifications and payment deferrals have been at historical high levels as the impact of the pandemic continues. As of September 30, 2021, the loan modification/deferral program in place has generated deferrals of up to 180 days that have been granted on 1,371 loans with 14 loans remaining in their deferral period with an aggregate outstanding balance of $1,346,000. These loan modifications met applicable requirements to not be considered troubled debt restructurings. The Economic Aid to Hard-Hit Small Businesses, Non-profits and Venues Act (the “Economic Aid Act”) passed in December 2020 extended the CARES Act provisions permitting financial institutions to suspend TDR assessment and reporting requirements under generally accepted accounting principles until the earlier of 60 days after the date that the President terminates the COVID-19 national emergency or January 1, 2022. The number of customers seeking loan modifications or payment deferrals may increase as the effects of the pandemic continue. Internal Risk Ratings Management uses a ten point internal risk rating system to monitor the credit quality of the overall loan portfolio. The first six categories are considered not criticized, and are aggregated as “Pass” rated. The criticized rating categories utilized by management generally follow bank regulatory definitions. The special mention category includes assets that are currently protected but are potentially weak, resulting in an undue and unwarranted credit risk, but not to the point of justifying a substandard classification. Loans in the substandard category have well-defined weaknesses that jeopardize the liquidation of the debt, and have a distinct possibility that some loss will be sustained if the weaknesses are not corrected. All loans greater than 90 days past due are evaluated for substandard classification. Loans in the doubtful category exhibit the same weaknesses found in the substandard loans, however, the weaknesses are more pronounced. Such loans are static and collection in full is improbable. However, these loans are not yet rated as loss because certain events may occur which would salvage the debt. Loans classified loss are considered uncollectible and charge-off is imminent. To help ensure that risk ratings are accurate and reflect the present and future capacity of borrowers to repay a loan as agreed, the Banks have a structured loan rating process with several layers of internal and external oversight. Generally, consumer and residential mortgage loans are included in the pass category unless a specific action, such as bankruptcy, repossession, or death occurs to raise awareness of a possible credit event. An external semi-annual loan review of large commercial relationships is performed, as well as a sample of smaller transactions. The 2021 loan review has an aggregate commercial relationship threshold of $1,750,000 which can consist of outstanding loans, commercial real estate mortgages and outstanding commitments. Detailed reviews, including plans for resolution, are performed on loans classified as substandard, doubtful, or loss on a quarterly basis. The following table presents the credit quality categories identified above as of September 30, 2021 and December 31, 2020: September 30, 2021 Commercial, Financial, and Agricultural Real Estate Mortgages Consumer automobile Other consumer installment loans (In Thousands) Residential Commercial Construction Totals Pass $ 176,189 $ 584,538 $ 360,033 $ 45,144 $ 146,663 $ 9,718 $ 1,322,285 Special Mention 442 240 6,160 686 — — 7,528 Substandard 3,017 3,147 10,817 118 — 19 17,118 $ 179,648 $ 587,925 $ 377,010 $ 45,948 $ 146,663 $ 9,737 $ 1,346,931 December 31, 2020 Commercial, Financial, and Agricultural Real Estate Mortgages Consumer automobile Other consumer installment loans (In Thousands) Residential Commercial Construction Totals Pass $ 162,694 $ 584,599 $ 355,616 $ 39,192 $ 156,403 $ 19,938 $ 1,318,442 Special Mention 180 556 7,973 — — — 8,709 Substandard 1,869 4,566 9,599 117 — 2 16,153 $ 164,743 $ 589,721 $ 373,188 $ 39,309 $ 156,403 $ 19,940 $ 1,343,304 Allowance for Loan Losses An allowance for loan losses (“ALL”) is maintained to absorb losses from the loan portfolio. The ALL is based on management’s continuing evaluation of the risk characteristics and credit quality of the loan portfolio, assessment of current economic conditions, diversification and size of the portfolio, adequacy of collateral, past and anticipated future loss experience, and the amount of non-performing loans. The Banks' methodology for determining the ALL is based on the requirements of ASC Section 310-10-35 for loans individually evaluated for impairment (previously discussed) and ASC Subtopic 450-20 for loans collectively evaluated for impairment, as well as the Interagency Policy Statements on the Allowance for Loan and Lease Losses and other bank regulatory guidance. The total of the two components represents the Banks' ALL. Loans that are collectively evaluated for impairment are analyzed with general allowances being made as appropriate. Allowances are segmented based on collateral characteristics previously disclosed, and consistent with credit quality monitoring. Loans that are collectively evaluated for impairment are grouped into two classes for evaluation. A general allowance is determined for “Pass” rated credits, while a separate pool allowance is provided for “Criticized” rated credits that are not individually evaluated for impairment. For the general allowances, historical loss trends are used in the estimation of losses in the current portfolio. These historical loss amounts are modified by other qualitative factors. A historical charge-off factor is calculated utilizing a twelve quarter moving average. However, management may adjust the moving average time frame by up to four quarters to adjust for variances in the economic cycle. Management has identified a number of additional qualitative factors which it uses to supplement the historical charge-off factor because these factors are likely to cause estimated credit losses associated with the existing loan pools to differ from historical loss experience. The additional factors that are evaluated quarterly and updated using information obtained from internal, regulatory, and governmental sources are: national and local economic trends and conditions; levels of and trends in delinquency rates and non-accrual loans; trends in volumes and terms of loans; effects of changes in lending policies; experience, ability, and depth of lending staff; value of underlying collateral; and concentrations of credit from a loan type, industry and/or geographic standpoint. Loans in the criticized pools, which possess certain qualities or characteristics that may lead to collection and loss issues, are closely monitored by management and subject to additional qualitative factors. Management also monitors industry loss factors by loan segment for applicable adjustments to actual loss experience. Management reviews the loan portfolio on a quarterly basis in order to make appropriate and timely adjustments to the ALL. When information confirms all or part of specific loans to be uncollectible, these amounts are promptly charged off against the ALL. Activity in the allowance is presented for the three and nine months ended September 30, 2021 and 2020: Three Months Ended September 30, 2021 Commercial, Financial, and Agricultural Real Estate Mortgages Consumer automobile Other consumer installment (In Thousands) Residential Commercial Construction Unallocated Totals Beginning Balance $ 1,846 $ 4,619 $ 4,436 $ 212 $ 1,824 $ 44 $ 1,457 $ 14,438 Charge-offs (10) (29) — — (12) (116) — (167) Recoveries 8 — 84 5 107 7 — 211 Provision 277 175 (500) 11 (226) 194 144 75 Ending Balance $ 2,121 $ 4,765 $ 4,020 $ 228 $ 1,693 $ 129 $ 1,601 $ 14,557 Three Months Ended September 30, 2020 Commercial, Financial, and Agricultural Real Estate Mortgages Consumer automobile Other consumer installment (In Thousands) Residential Commercial Construction Unallocated Totals Beginning Balance $ 1,953 $ 4,478 $ 3,335 $ 150 $ 2,214 $ 127 $ 720 $ 12,977 Charge-offs — (6) — — (200) (33) — (239) Recoveries 9 1 — — 10 26 — 46 Provision 17 (24) (290) 20 (27) 135 814 645 Ending Balance $ 1,979 $ 4,449 $ 3,045 $ 170 $ 1,997 $ 255 $ 1,534 $ 13,429 t Nine Months Ended September 30, 2021 Commercial, Financial, and Agricultural Real Estate Mortgages Consumer automobile Other consumer installment (In Thousands) Residential Commercial Construction Unallocated Totals Beginning Balance $ 1,936 $ 4,460 $ 3,635 $ 134 $ 1,906 $ 261 $ 1,471 $ 13,803 Charge-offs (45) (172) — — (235) (173) — (625) Recoveries 22 112 109 10 139 47 — 439 Provision 208 365 276 84 (117) (6) 130 940 Ending Balance $ 2,121 $ 4,765 $ 4,020 $ 228 $ 1,693 $ 129 $ 1,601 $ 14,557 Nine Months Ended September 30, 2020 Commercial, Financial, and Agricultural Real Estate Mortgages Consumer automobile Other consumer installment (In Thousands) Residential Commercial Construction Unallocated Totals Beginning Balance $ 1,779 $ 4,306 $ 3,210 $ 118 $ 1,780 $ 278 $ 423 $ 11,894 Charge-offs (22) (174) — — (289) (215) — (700) Recoveries 32 48 — 5 17 93 — 195 Provision 190 269 (165) 47 489 99 1,111 2,040 Ending Balance $ 1,979 $ 4,449 $ 3,045 $ 170 $ 1,997 $ 255 $ 1,534 $ 13,429 The shift in allocation and the decrease in the loan provision is primarily due to changes in the credit metrics within the loan portfolio, several commercial loans with specific loan loss allocations being paid off, and the economic uncertainty caused by the COVID-19 pandemic including supply chain disruptions. The Company grants commercial, industrial, residential, and installment loans to customers primarily throughout north-east and central Pennsylvania. Although the Company has a diversified loan portfolio, a substantial portion of its debtors’ ability to honor their contracts is dependent on the economic conditions within this region. The Company has a concentration of the following to gross loans at September 30, 2021 and 2020: September 30, 2021 2020 Owners of residential rental properties 18.84 % 16.29 % Owners of commercial rental properties 14.03 % 12.98 % The following table presents the balance in the allowance for loan losses and the recorded investment in loans by portfolio segment based on impairment method as of September 30, 2021 and December 31, 2020: September 30, 2021 Commercial, Financial, and Agricultural Real Estate Mortgages Consumer Automobile Other consumer installment Unallocated (In Thousands) Residential Commercial Construction Totals Allowance for Loan Losses: Ending allowance balance attributable to loans: Individually evaluated for impairment $ 2 $ 246 $ 902 $ — $ — $ 20 $ — $ 1,170 Collectively evaluated for impairment 2,119 4,519 3,118 228 1,693 109 1,601 13,387 Total ending allowance balance $ 2,121 $ 4,765 $ 4,020 $ 228 $ 1,693 $ 129 $ 1,601 $ 14,557 Loans: Individually evaluated for impairment $ 1,685 $ 5,276 $ 10,285 $ 114 $ — $ 20 $ 17,380 Collectively evaluated for impairment 177,963 582,649 366,725 45,834 146,663 9,717 1,329,551 Total ending loans balance $ 179,648 $ 587,925 $ 377,010 $ 45,948 $ 146,663 $ 9,737 $ 1,346,931 December 31, 2020 Commercial, Financial, and Agricultural Real Estate Mortgages Consumer Automobile Other consumer installment Unallocated (In Thousands) Residential Commercial Construction Totals Allowance for Loan Losses: Ending allowance balance attributable to loans: Individually evaluated for impairment $ — $ 224 $ 811 $ — $ — $ — $ — $ 1,035 Collectively evaluated for impairment 1,936 4,236 2,824 134 1,906 261 1,471 12,768 Total ending allowance balance $ 1,936 $ 4,460 $ 3,635 $ 134 $ 1,906 $ 261 $ 1,471 $ 13,803 Loans: Individually evaluated for impairment $ 865 $ 6,317 $ 9,377 $ 124 $ — $ — $ 16,683 Collectively evaluated for impairment 163,878 583,404 363,811 39,185 156,403 19,940 1,326,621 Total ending loans balance $ 164,743 $ 589,721 $ 373,188 $ 39,309 $ 156,403 $ 19,940 $ 1,343,304 |
Net Periodic Benefit Cost-Defin
Net Periodic Benefit Cost-Defined Benefit Plans | 9 Months Ended |
Sep. 30, 2021 | |
Pension and Other Postretirement Benefits Cost (Reversal of Cost) [Abstract] | |
Net Periodic Benefit Cost-Defined Benefit Plans | Net Periodic Benefit Cost-Defined Benefit PlansFor a detailed disclosure on the Company’s pension and employee benefits plans, please refer to Note 13 of the Company’s Consolidated Financial Statements included in the Annual Report on Form 10-K for the year ended December 31, 2020. The following sets forth the components of the net periodic benefit/cost of the domestic non-contributory defined benefit plan for the three and nine months ended September 30, 2021 and 2020, respectively: Three Months Ended September 30, Nine Months Ended September 30, (In Thousands) 2021 2020 2021 2020 Interest cost $ 127 $ 161 $ 381 $ 481 Expected return on plan assets (386) (330) (1,158) (956) Amortization of net loss 45 52 138 144 Net periodic benefit $ (214) $ (117) $ (639) $ (331) Employer Contributions The Company previously disclosed in its consolidated financial statements, included in the Annual Report on Form 10-K for the year ended December 31, 2020, that it expected to contribute a minimum of $500,000 to its defined benefit plan in 2021. As of September 30, 2021, there were contributions of $600,000 made to the plan with additional contributions of at least $100,000 anticipated during the remainder of 2021. |
Employee Stock Purchase Plan
Employee Stock Purchase Plan | 9 Months Ended |
Sep. 30, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Employee Stock Purchase Plan | Employee Stock Purchase PlanThe Company maintains an Employee Stock Purchase Plan (“Plan”). The Plan is intended to encourage employee participation in the ownership and economic progress of the Company. The Plan allows for up to 1,500,000 shares to be purchased by employees. The purchase price of the shares is 95% of market value with an employee eligible to purchase up to the lesser of 15% of base compensation or $12,000 in market value annually. During the nine months ended September 30, 2021 and 2020, there were 2,873 and 2,888 shares issued under the Plan, respectively. |
Off-Balance Sheet Risk
Off-Balance Sheet Risk | 9 Months Ended |
Sep. 30, 2021 | |
Off Balance Sheet Risk | |
Off-Balance Sheet Risk | Off-Balance Sheet Risk The Company is a party to financial instruments with off-balance sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments are primarily comprised of commitments to extend credit, standby letters of credit, and credit exposure from the sale of assets with recourse. These instruments involve, to varying degrees, elements of credit, interest rate, or liquidity risk in excess of the amount recognized in the Consolidated Balance Sheet. The contract amounts of these instruments express the extent of involvement the Company has in particular classes of financial instruments. The Company’s exposure to credit loss from nonperformance by the other party to the financial instruments for commitments to extend credit and standby letters of credit is represented by the contractual amount of these instruments. The Company uses the same credit policies in making commitments and conditional obligations as it does for on-balance sheet instruments. The Company may require collateral or other security to support financial instruments with off-balance sheet credit risk. Financial instruments whose contract amounts represent credit risk are as follows at September 30, 2021 and December 31, 2020: (In Thousands) September 30, 2021 December 31, 2020 Commitments to extend credit $ 236,397 $ 198,512 Standby letters of credit 9,949 10,120 Credit exposure from the sale of assets with recourse 10,031 9,182 $ 256,377 $ 217,814 Commitments to extend credit are legally binding agreements to lend to customers. Commitments generally have fixed expiration dates or other termination clauses and may require payment of fees. Since many of the commitments are expected to expire without being drawn upon, the total commitment amounts do not necessarily represent future liquidity requirements. The Company evaluates each customer’s credit worthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary by the Company, on an extension of credit is based on management’s credit assessment of the counterparty. Standby letters of credit represent conditional commitments issued by the Company to guarantee the performance of a customer to a third party. These instruments are issued primarily to support bid or performance related contracts. The coverage period for these instruments is typically a one year period with an annual renewal option subject to prior approval by management. |
Fair Value Measurements
Fair Value Measurements | 9 Months Ended |
Sep. 30, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements The following disclosures show the hierarchal disclosure framework associated with the level of pricing observations utilized in measuring assets and liabilities at fair value. Level I: Quoted prices are available in active markets for identical assets or liabilities as of the reported date. Level II: Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reported date. The nature of these assets and liabilities include items for which quoted prices are available but traded less frequently, and items that are fair valued using other financial instruments, the parameters of which can be directly observed. Level III: Assets and liabilities that have little to no pricing observability as of the reported date. These items do not have two-way markets and are measured using management’s best estimate of fair value, where the inputs into the determination of fair value require significant management judgment or estimation. This hierarchy requires the use of observable market data when available. The following table presents the assets reported on the Consolidated Balance Sheet at their fair value on a recurring basis as of September 30, 2021 and December 31, 2020, by level within the fair value hierarchy. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. September 30, 2021 (In Thousands) Level I Level II Level III Total Assets measured on a recurring basis: Investment securities, available for sale: Mortgage-backed securities $ — $ 1,775 $ — $ 1,775 State and political securities — 116,474 — 116,474 Other debt securities — 48,511 — 48,511 Investment equity securities: Other equity securities 1,263 — — 1,263 Investment securities, trading: Other equity securities 40 — — 40 December 31, 2020 (In Thousands) Level I Level II Level III Total Assets measured on a recurring basis: Investment securities, available for sale: Mortgage-backed securities $ — $ 2,141 $ — $ 2,141 State and political securities — 108,013 — 108,013 Other debt securities — 52,107 — 52,107 Investment equity securities: Other equity securities 1,288 — — 1,288 Investment securities, trading: Other equity securities 40 — — 40 The following table presents the assets reported on the Consolidated Balance Sheet at their fair value on a non-recurring basis as of September 30, 2021 and December 31, 2020, by level within the fair value hierarchy. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. September 30, 2021 (In Thousands) Level I Level II Level III Total Assets measured on a non-recurring basis: Impaired loans $ — $ — $ 16,210 $ 16,210 Other real estate owned — — 83 83 December 31, 2020 (In Thousands) Level I Level II Level III Total Assets measured on a non-recurring basis: Impaired loans $ — $ — $ 15,648 $ 15,648 Other real estate owned — — 401 401 The following tables present a listing of significant unobservable inputs used in the fair value measurement process for items valued utilizing level III techniques as of September 30, 2021 and December 31, 2020: September 30, 2021 Quantitative Information About Level III Fair Value Measurements (In Thousands) Fair Value Valuation Technique(s) Unobservable Inputs Range Weighted Average Impaired loans $ 13,826 Discounted cash flow Temporary reduction in payment amount 3% to (63)% (7)% 2,384 Appraisal of collateral (1) Appraisal adjustments (1) 0% to (30)% (15)% Other real estate owned $ 83 Appraisal of collateral (1) Appraisal adjustments (1) (20)% (20)% (1) Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. December 31, 2020 Quantitative Information About Level III Fair Value Measurements (In Thousands) Fair Value Valuation Technique(s) Unobservable Inputs Range Weighted Average Impaired loans $ 8,624 Discounted cash flow Temporary reduction in payment amount 17% to (63)% (18)% 7,024 Appraisal of collateral (1) Appraisal adjustments (1) 0% to (30)% (8)% Other real estate owned $ 401 Appraisal of collateral (1) Appraisal adjustments (1) (20)% (20)% (1) Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The discounted cash flow valuation technique is utilized to determine the fair value of performing impaired loans, while non-performing impaired loans utilize the appraisal of collateral method. The significant unobservable inputs used in the fair value measurement of the Company’s impaired loans using the discounted cash flow valuation technique include temporary changes in payment amounts and the probability of default. Significant increases (decreases) in payment amounts would result in significantly higher (lower) fair value measurements. The probability of default is 0% for impaired loans using the discounted cash flow valuation technique because all defaulted impaired loans are valued using the appraisal of collateral valuation technique. |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 9 Months Ended |
Sep. 30, 2021 | |
Fair Value Disclosures [Abstract] | |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The Company is required to disclose fair values for its financial instruments. Fair values are made at a specific point in time, based on relevant market information and information about the financial instrument. These estimates do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument. Also, it is the Company’s general practice and intention to hold most of its financial instruments to maturity and not to engage in trading or sales activities. Because no market exists for a significant portion of the Company’s financial instruments, fair value estimates are based on judgments regarding future expected loss experience, current economic conditions, risk characteristics of various financial instruments, and other factors. These fair values are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions can significantly affect the fair values. Fair values have been determined by the Company using historical data and an estimation methodology suitable for each category of financial instruments. The Company’s fair values, methods, and assumptions are set forth below for the Company’s other financial instruments. As certain assets and liabilities, such as deferred tax assets, premises and equipment, and many other operational elements of the Company, are not considered financial instruments but have value, this fair value of financial instruments would not represent the full market value of the Company. The fair values of the Company’s financial instruments not recorded at fair value on a recurring or nonrecurring basis are as follows at September 30, 2021 and December 31, 2020: Carrying Fair Fair Value Measurements at September 30, 2021 (In Thousands) Value Value Level I Level II Level III Financial assets: Cash and cash equivalents (1) $ 281,647 $ 281,647 $ 281,647 $ — $ — Restricted investment in bank stock (1) 14,649 14,649 14,649 — — Loans held for sale (1) 3,246 3,246 3,246 — — Loans, net 1,332,668 1,340,252 — — 1,340,252 Bank-owned life insurance (1) 33,836 33,836 33,836 — — Accrued interest receivable (1) 8,529 8,529 8,529 — — Financial liabilities: Interest-bearing deposits $ 1,111,144 $ 1,114,193 $ 876,786 $ — $ 237,407 Noninterest-bearing deposits (1) 481,875 481,875 481,875 — — Short-term borrowings (1) 9,404 9,404 9,404 — — Long-term borrowings 126,007 129,392 — — 129,392 Accrued interest payable (1) 828 828 828 — — (1) The financial instrument is carried at cost at September 30, 2021, which approximate the fair value of the instruments Carrying Fair Fair Value Measurements at December 31, 2020 (In Thousands) Value Value Level I Level II Level III Financial assets: Cash and cash equivalents (1) $ 213,358 $ 213,358 $ 213,358 $ — $ — Restricted investment in bank stock (1) 15,377 15,377 15,377 — — Loans held for sale (1) 5,239 5,239 5,239 — — Loans, net 1,330,524 1,339,993 — — 1,339,993 Bank-owned life insurance (1) 33,638 33,638 33,638 — — Accrued interest receivable (1) 8,394 8,394 8,394 — — Financial liabilities: Interest-bearing deposits $ 1,045,086 $ 1,048,281 $ 781,441 $ — $ 266,840 Noninterest-bearing deposits (1) 449,357 449,357 449,357 — — Short-term borrowings (1) 5,244 5,244 5,244 — — Long-term borrowings 153,475 159,575 — — 159,575 Accrued interest payable (1) 1,112 1,112 1,112 — — (1) The financial instrument is carried at cost at December 31, 2020, which approximate the fair value of the instruments The methods and assumptions used by the Company in estimating fair values of financial instruments at September 30, 2021 is in accordance with ASC Topic 825, Financial Instruments , as amended by ASU 2016-01 which requires public entities to use exit pricing in the calculation of the above tables. |
Stock Options
Stock Options | 9 Months Ended |
Sep. 30, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Stock Options | Stock Options In 2020, the Company adopted the 2020 Equity Incentive Plan which replaced the 2014 Equity Incentive Plan that did not have any remaining shares available for issuance. The plans are designed to help the Company attract, retain, and motivate employees and non-employee directors. Incentive stock options, non-qualified stock options, restricted stock, restricted stock units, and other equity-based awards may be granted as part of the plan. As of January 1, 2021, the Company had a total of 841,275 stock options outstanding. During the period ended September 30, 2021, the Company issued 234,500 stock options with a strike price of $24.23 to a group of employees. The options granted in 2021 all expire ten years from the grant date. Of the 234,500 grants awarded in 2021, 156,500 of the options vest in three years while the 78,000 remaining options vest in five years. Stock Options Granted Date Shares Forfeited Outstanding Strike Price Vesting Period Expiration April 9, 2021 156,500 — 156,500 $ 24.23 3 years 10 years April 9, 2021 78,000 — 78,000 24.23 5 years 10 years March 11, 2020 119,300 — 119,300 25.31 3 years 10 years March 11, 2020 119,200 — 119,200 25.31 5 years 10 years March 15, 2019 120,900 (12,900) 108,000 28.01 3 years 10 years March 15, 2019 119,100 (12,600) 106,500 28.01 5 years 10 years August 24, 2018 75,300 (9,900) 65,400 30.67 3 years 10 years August 24, 2018 149,250 (19,800) 129,450 30.67 5 years 10 years January 5, 2018 18,750 — 18,750 30.07 3 years 10 years January 5, 2018 18,750 — 18,750 30.07 5 years 10 years March 24, 2017 69,375 (11,250) 58,125 29.47 3 years 10 years March 24, 2017 35,625 (2,250) 33,375 29.47 5 years 10 years August 27, 2015 58,125 (24,000) 34,125 28.02 5 years 10 years A summary of stock option activity is presented below: September 30, 2021 September 30, 2020 Shares Weighted Average Exercise Price Shares Weighted Average Exercise Price Outstanding, beginning of year 841,275 $ 28.17 625,800 $ 29.29 Granted 234,500 24.23 238,500 25.34 Exercised — — — — Forfeited (30,300) 29.33 — — Expired — — — — Outstanding, end of period 1,045,475 $ 27.25 864,300 $ 28.20 Exercisable, end of period 176,400 $ 29.70 97,875 $ 28.95 The estimated fair value of options, including the effect of estimated forfeitures, is recognized as expense on a straightline basis over the options’ vesting periods while ensuring that the cumulative amount of compensation cost recognized at least equals the value of the vested portion of the award at that date. The Company determines the fair value of options granted using the Black-Scholes option-pricing model. The risk-free interest rate is based on the United States Treasury bond with a similar term to the expected life of the options at the grant date. Expected volatility was estimated based on the adjusted historic volatility of the Company’s shares. The expected life was estimated to equal the contractual life of the options. The dividend yield rate was based upon recent historical dividends paid on shares. |
Leases
Leases | 9 Months Ended |
Sep. 30, 2021 | |
Leases [Abstract] | |
Leases | Leases The following table shows finance lease right of use assets and finance lease liabilities as of: (In Thousands) Statement of Financial Condition classification September 30, 2021 December 31, 2020 Finance lease right of use assets Premises and equipment, net $ 7,543 $ 5,257 Finance lease liabilities Long-term borrowings 8,007 5,475 The following table shows the components of finance and operating lease expense for the three and nine months ended September 30, 2021 and 2020: Three Months Ended September 30, Nine Months Ended September 30, (In Thousands) 2021 2020 2021 2020 Finance Lease Cost: Amortization of right-of-use asset $ 108 $ 50 $ 367 $ 150 Interest expense 62 53 195 159 Operating lease cost 73 76 223 243 Variable lease cost — — — — Total Lease Cost $ 243 $ 179 $ 785 $ 552 A maturity analysis of operating and finance lease liabilities and reconciliation of the undiscounted cash flows to the total operating lease liability is as follows: (In Thousands) Operating Finance 2021 $ 71 $ 104 2022 290 420 2023 265 421 2024 255 427 2025 257 929 2026 and thereafter 2,829 9,664 Total undiscounted cash flows 3,967 11,965 Discount on cash flows (1,020) (3,958) Total lease liability $ 2,947 $ 8,007 The following table shows the weighted average remaining lease term and weighted average discount rate for both operating and finance leases outstanding as of September 30, 2021. Operating Finance Weighted-average term (years) 17.8 24.6 Weighted-average discount rate 3.52 % 3.19 % |
Leases | Leases The following table shows finance lease right of use assets and finance lease liabilities as of: (In Thousands) Statement of Financial Condition classification September 30, 2021 December 31, 2020 Finance lease right of use assets Premises and equipment, net $ 7,543 $ 5,257 Finance lease liabilities Long-term borrowings 8,007 5,475 The following table shows the components of finance and operating lease expense for the three and nine months ended September 30, 2021 and 2020: Three Months Ended September 30, Nine Months Ended September 30, (In Thousands) 2021 2020 2021 2020 Finance Lease Cost: Amortization of right-of-use asset $ 108 $ 50 $ 367 $ 150 Interest expense 62 53 195 159 Operating lease cost 73 76 223 243 Variable lease cost — — — — Total Lease Cost $ 243 $ 179 $ 785 $ 552 A maturity analysis of operating and finance lease liabilities and reconciliation of the undiscounted cash flows to the total operating lease liability is as follows: (In Thousands) Operating Finance 2021 $ 71 $ 104 2022 290 420 2023 265 421 2024 255 427 2025 257 929 2026 and thereafter 2,829 9,664 Total undiscounted cash flows 3,967 11,965 Discount on cash flows (1,020) (3,958) Total lease liability $ 2,947 $ 8,007 The following table shows the weighted average remaining lease term and weighted average discount rate for both operating and finance leases outstanding as of September 30, 2021. Operating Finance Weighted-average term (years) 17.8 24.6 Weighted-average discount rate 3.52 % 3.19 % |
Reclassification of Comparative
Reclassification of Comparative Amounts | 9 Months Ended |
Sep. 30, 2021 | |
Reclassification of Comparative Amounts | |
Reclassification of Comparative Amounts | Reclassification of Comparative AmountsCertain comparative amounts for the prior period have been reclassified to conform to current period presentations. Such reclassifications had no effect on net income or shareholders’ equity. |
Subsequent Events
Subsequent Events | 9 Months Ended |
Sep. 30, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent EventsAll events subsequent to the date of the consolidated financial statements through November 9, 2021, and for which U.S. GAAP requires adjustment or disclosure, have been adjusted or disclosed, including that the 2019 novel coronavirus (or COVID-19) has adversely affected, and may continue to adversely affect, economic activity globally, nationally, and locally. In response to COVID-19, among other things, the Company has incurred loan rate modifications and payment deferrals of up to 180 days. For further discussion, see COVID-19 Impact section of Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operation. |
Risks and Uncertainties
Risks and Uncertainties | 9 Months Ended |
Sep. 30, 2021 | |
Risks and Uncertainties [Abstract] | |
Risks and Uncertainties | Risks and Uncertainties The impact of COVID-19 on the Corporation’s financial results is evolving and uncertain. The pandemic and its associated impacts on trade, travel, employee productivity, unemployment and consumer spending has resulted in less economic activity and volatility and disruption in the financial markets. The ultimate extent of the impact of the COVID-19 pandemic on the Company 's business, financial condition, and results of operations is currently uncertain and will depend on various developments and other factors, including, among others, the duration and scope of the pandemic, as well as governmental, regulatory, and private sector responses to the pandemic, and the associated impacts on the economy, financial markets and our customers, employees, and vendors. While the full effects of the pandemic remain unknown, the Company is committed to supporting its customers, employees, and communities during this difficult time. |
Basis of Presentation (Policies
Basis of Presentation (Policies) | 9 Months Ended |
Sep. 30, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | The consolidated financial statements include the accounts of Penns Woods Bancorp, Inc. (the “Company”) and its wholly-owned subsidiaries: Woods Investment Company, Inc., Woods Real Estate Development Company, Inc., Luzerne Bank, and Jersey Shore State Bank (Jersey Shore State Bank and Luzerne Bank are referred to together as the “Banks”) and Jersey Shore State Bank’s wholly-owned subsidiary, The M Group, Inc. D/B/A The Comprehensive Financial Group (“The M Group”). The Company also owned a controlling interest in United Insurance Solutions, LLC, which on October 15, 2021 became a wholly owned subsidiary of the Company. All significant inter-company balances and transactions have been eliminated in the consolidation. The interim financial statements are unaudited, but in the opinion of management reflect all adjustments necessary for the fair presentation of results for such periods. The results of operations for any interim period are not necessarily indicative of results for the full year. These financial statements should be read in conjunction with the financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. |
Recent Accounting Pronouncements | In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments , which changes the impairment model for most financial assets. This Update is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The underlying premise of the Update is that financial assets measured at amortized cost should be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. The allowance for credit losses should reflect management’s current estimate of credit losses that are expected to occur over the remaining life of a financial asset. The income statement will be affected for the measurement of credit losses for newly recognized financial assets, as well as the expected increases or decreases of expected credit losses that have taken place during the period. With certain exceptions, transition to the new requirements will be through a cumulative-effect adjustment to opening retained earnings as of the beginning of the first reporting period in which the guidance is adopted. This Update is effective for SEC filers that are eligible to be smaller reporting companies, non-SEC filers, and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We expect to recognize a one-time cumulative-effect adjustment to the allowance for loan losses as of the beginning of the first reporting period in which the new standard is effective but cannot yet determine the magnitude of any such one-time adjustment or the overall impact of the new guidance on the consolidated financial statements. In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment. To simplify the subsequent measurement of goodwill, the FASB eliminated Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under the amendments in this Update, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. The Update is effective for smaller reporting companies and all other entities for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. This Update is not expected to have a significant impact on the Company’s financial statements. In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments – Credit Losses, Derivatives, and Hedging (Topic 815); and Financial Instruments (Topic 825), which affects a variety of topics in the Codification and applies to all reporting entities within the scope of the affected accounting guidance. ASU 2019-04 makes clarifying amendments to certain financial instrument standards. For entities that have not yet adopted ASU 2016-13, the effective dates for the amendments related to ASU 2016-13 are the same as the effective dates in ASU 2016-13. For entities that have adopted ASU 2016-13, the amendments related to ASU 2016-13 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. For entities that have not yet adopted ASU 2017-12 as of April 25, 2019, the effective dates for the amendments to Topic 815 are the same as the effective dates in ASU 2017-12. For entities that have adopted ASU 2017-12 as of April 25, 2019, the effective date is as of the beginning of the first annual period beginning after April 25, 2019. The amendments related to ASU 2016-01 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company qualifies as a smaller reporting company and does not expect to early adopt these ASUs. In May 2019, the FASB issued ASU 2019-05, Financial Instruments – Credit Losses (Topic 326) , which allows entities to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost upon adoption of the new credit losses standard. To be eligible for the transition election, the existing financial asset must otherwise be both within the scope of the new credit losses standard and eligible for applying the fair value option in ASC 825-10.3. The election must be applied on an instrument-by-instrument basis and is not available for either available-for-sale or held-to-maturity debt securities. For entities that elect the fair value option, the difference between the carrying amount and the fair value of the financial asset would be recognized through a cumulative-effect adjustment to opening retained earnings as of the date an entity adopted ASU 2016-13. Changes in fair value of that financial asset would subsequently be reported in current earnings. For entities that have not yet adopted the credit losses standard, the ASU is effective when they implement the credit losses standard. For entities that already have adopted the credit losses standard, the ASU is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company qualifies as a smaller reporting company and does not expect to early adopt ASU 2016-13. In November 2019, the FASB issued ASU 2019-11, Codification Improvements to Topic 326, Financial Instruments – Credit Losses , to clarify its new credit impairment guidance in ASC 326, based on implementation issues raised by stakeholders. This Update clarified, among other things, that expected recoveries are to be included in the allowance for credit losses for these financial assets; an accounting policy election can be made to adjust the effective interest rate for existing troubled debt restructurings based on the prepayment assumptions instead of the prepayment assumptions applicable immediately prior to the restructuring event; and extends the practical expedient to exclude accrued interest receivable from all additional relevant disclosures involving amortized cost basis. For entities that have not yet adopted ASU 2016-13 as of November 26, 2019, the effective dates for ASU 2019-11 are the same as the effective dates and transition requirements in ASU 2016-13. For entities that have adopted ASU 2016-13, ASU 2019-11 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. The Company qualifies as a smaller reporting company and does not expect to early adopt these ASUs. In March 2020, the FASB issued ASU 2020-03, Codification Improvements to Financial Instruments . This ASU was issued to improve and clarify various financial instruments topics, including the current expected credit losses (CECL) standard issued in 2016. The ASU includes seven issues that describe the areas of improvement and the related amendments to GAAP; they are intended to make the standards easier to understand and apply and to eliminate inconsistencies, and they are narrow in scope and are not expected to significantly change practice for most entities. Among its provisions, the ASU clarifies that all entities, other than public business entities that elected the fair value option, are required to provide certain fair value disclosures under ASC 825, Financial Instruments, in both interim and annual financial statements. It also clarifies that the contractual term of a net investment in a lease under Topic 842 should be the contractual term used to measure expected credit losses under Topic 326. Amendments related to ASU 2019-04 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is not permitted before an entity’s adoption of ASU 2016-01. Amendments related to ASU 2016-13 for entities that have not yet adopted that guidance are effective upon adoption of the amendments in ASU 2016-13. Early adoption is not permitted before an entity’s adoption of ASU 2016-13. Amendments related to ASU 2016-13 for entities that have adopted that guidance are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. Other amendments are effective upon issuance of this ASU. The Company is currently evaluating the impact the adoption of the standard will have on the Company’s financial position or results of operations. In January 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, March 2020 , to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as the Secured Overnight Financing Rate. Entities can elect not to apply certain modification accounting requirements to contracts affected by what the guidance calls “reference rate reform” if certain criteria are met. An entity that makes this election would not have to remeasure the contracts at the modification date or reassess a previous accounting determination. Also, entities can elect various optional expedients that would allow them to continue applying hedge accounting for hedging relationships affected by reference rate reform if certain criteria are met, and can make a one-time election to sell and/or reclassify held-to-maturity debt securities that reference an interest rate affected by reference rate reform. The amendments in this ASU are effective for all entities upon issuance through December 31, 2022. It is too early to predict whether a new rate index replacement and the adoption of the ASU will have a material impact on the Company’s financial statements. In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40) , which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity’s own equity. This ASU removes from U.S. GAAP the separation models for (1) convertible debt with a cash conversion feature and (2) convertible instruments with a beneficial conversion feature. As a result, entities will not separately present in equity an embedded conversion feature in such debt. Instead, they will account for a convertible debt instrument wholly as debt, and for convertible preferred stock wholly as preferred stock (i.e., as a single unit of account), unless (1) a convertible instrument contains features that require bifurcation as a derivative under ASC 815 or (2) a convertible debt instrument was issued at a substantial premium. This ASU requires entities to provide expanded disclosures about the terms and features of convertible instruments, how the instruments have been reported in the entity’s financial statements, and information about events, conditions, and circumstances that can affect how to assess the amount or timing of an entity’s future cash flows related to those instruments. The amendments in this ASU are effective for public business entities that are not smaller reporting companies, for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. For all other entities, this ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The guidance may be early adopted for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years. This Update is not expected to have a significant impact on the Company’s financial statements. In October 2020, the FASB issued ASU 2020-08, Codification Improvements to Subtopic 310-20, Receivables – Nonrefundable Fees and Other Costs, which clarifies that, for each reporting period, an entity should reevaluate whether a callable debt security is within the scope of ASC 310-20-35-33. For public business entities, ASU 2020-08 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is not permitted. For all other entities, ASU 2020-08 is effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. This Update is not expected to have a significant impact on the Company’s financial statements. In October 2020, the FASB issued ASU 2020-09, Debt (Topic 470): Amendments to SEC Paragraphs Pursuant to SEC Release No. 33-10762 , which codifies, as appropriate, the amended financial statement disclosure requirements in Regulation S-X Rules 13-01 and 13-02. The amendments were effective January 4, 2021. This Update did not have a significant impact on the Company’s financial statements. In October 2020, the FASB issued ASU 2020-10, Codification Improvements , which makes minor technical corrections and clarifications to the ASC. The amendments in Sections B and C of the ASU are effective for annual periods beginning after December 15, 2020, for public business entities. For all other entities, the amendments are effective for annual periods beginning after December 15, 2021, and interim periods within annual periods beginning after December 15, 2022. This Update is not expected to have a significant impact on the Company’s financial statements. In November 2020, the FASB issued ASU 2020-11, Financial Services – Insurance (Topic 944) , which was made in consideration of the implications of the Coronavirus Disease 2019 (COVID-19) pandemic on an insurance entity’s ability to effectively implement the amendments in Accounting Standards Update No. 2018-12, Financial Services— Insurance: Targeted Improvements to the Accounting for Long-Duration Contracts (LDTI). The amendments in this Update defer the effective date of LDTI for all entities by one year, as (1) for public business entities that meet the definition of an SEC filer and are not SRCs, LDTI is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years; and (2) for all other entities, LDTI is effective for fiscal years beginning after December 15, 2024, and interim periods within fiscal years beginning after December 15, 2025. This Update is not expected to have a significant impact on the Company’s financial statements. In January 2021, the FASB issued ASU 2021-01, Reference Rate Reform (Topic 848) , which provides optional temporary guidance for entities transitioning away from the London Interbank Offered Rate (LIBOR) and other interbank offered rates (IBORs) to new references rates so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions within Topic 848. ASU 2021-01 clarifies that the derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. ASU 2021-01 is effective immediately for all entities. Entities may elect to apply the amendments on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or on a prospective basis to new modifications from any date within an interim period that includes or is subsequent to the date of the issuance of a final update, up to the date that financial statements are available to be issued. The amendments in this update do not apply to contract modifications made, as well as new hedging relationships entered into, after December 31, 2022, and to existing hedging relationships evaluated for effectiveness for periods after December 31, 2022, except for certain hedging relationships existing as of December 31, 2022, that apply certain optional expedients in which the accounting effects are recorded through the end of the hedging relationship. The Company is currently evaluating the impact the adoption of the standard will have on the Company’s financial position or results of operations. In May 2021, the FASB issued ASU 2021-04, Earnings Per Share (Topic 260), Debt – Modifications and Extinguishments (Subtopic 470-50), Compensation – Stock Compensation (Topic 718), and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40), which requires an entity to treat a modification of an equity-classified warrant that does not cause the warrant to become liability-classified as an exchange of the original warrant for a new warrant. This guidance applies whether the modification is structured as an amendment to the terms and conditions of the warrant or as termination of the original warrant and issuance of a new warrant. An entity should measure the effect of a modification as the difference between the fair value of the modified warrant and the fair value of that warrant immediately before modification. The amendments in this Update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. An entity should apply the amendments prospectively to modifications or exchanges occurring on or after the effective date of the amendments. Early adoption is permitted for all entities, including adoption in an interim period. If an entity elects to early adopt the amendments in this Update in an interim period, the guidance should be applied as of the beginning of the fiscal year that includes that interim period. This Update is not expected to have a significant impact on the Company’s financial statements. In July 2021, the FASB issued ASU 2021-05, Leases (Topic 842), which amends ASC 842 so that lessors are no longer required to recognize a selling loss upon commencement of a lease with variable lease payments that, prior to the amendments, would have been classified as a sales-type or direct financing lease. Furthermore, a lessor must classify as an operating lease any lease that would otherwise be classified as a sales-type or direct financing lease and that would result in the recognition of a selling loss at lease commencement, provided that the lease includes variable lease payments that do not depend on an index or rate. For public business entities and certain not-for-profit entities and employee benefit plans that have adopted ASC 842, the amendments are effective for fiscal years beginning after December 15, 2021, and for interim periods within those fiscal years. For all other entities that have adopted ASC 842, the amendments are effective for fiscal years beginning after December 15, 2021, and for interim periods within fiscal years beginning after December 15, 2022. All entities that have adopted ASC 842 are permitted to early adopt the amendments in ASU 2021-05. The amendments in ASU 2021-05 are effective as of the same date as the guidance in ASC 842 for entities that have not adopted ASC 842. This Update is not expected to have a significant impact on the Company’s financial statements. In August 2021, the FASB issued ASU 2021-06, Presentation of Financial Statements (Topic 205), Financial Services – Depository and Lending (Topic 942), and Financial Services – Investment Companies (Topic 946): Amendments to SEC Paragraphs Pursuant to SEC Final Rule Releases No. 33-10786, Amendments to Financial Disclosures about Acquired and Disposed Businesses, and No. 33-10835, Update of Statistical Disclosures for Bank and Savings and Loan Registrants (SEC Update) , to amend SEC paragraphs in the Accounting Standards Codification to reflect the issuance of SEC Release No. 33-10786, Amendments to Financial Disclosures about Acquired and Disposed Businesses , and No. 33-10835, Update of Statistical Disclosures for Bank and Savings and Loan Registrants |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Gain (loss) (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] | |
Schedule of changes in accumulated other comprehensive income by component | The changes in accumulated other comprehensive gain (loss) by component shown net of tax and parenthesis indicating debits, as of September 30, 2021 and 2020 were as follows: Three Months Ended September 30, 2021 Three Months Ended September 30, 2020 (In Thousands) Net Unrealized Gain on Available Defined Total Net Unrealized Defined Total Beginning balance $ 4,085 $ (5,523) $ (1,438) $ 4,194 $ (5,159) $ (965) Other comprehensive (loss) gain before reclassifications (542) — (542) 1,046 — 1,046 Amounts reclassified from accumulated other comprehensive (loss) gain (39) 37 (2) (800) 41 (759) Net current-period other comprehensive (loss) income (581) 37 (544) 246 41 287 Ending balance $ 3,504 $ (5,486) $ (1,982) $ 4,440 $ (5,118) $ (678) Nine Months Ended September 30, 2021 Nine Months Ended September 30, 2020 (In Thousands) Net Unrealized Gain (Loss) on Available for Sale Securities Defined Total Net Unrealized Gain (Loss) on Available Defined Total Beginning balance $ 4,714 $ (5,596) $ (882) $ 2,455 $ (5,232) $ (2,777) Other comprehensive gain (loss) before reclassifications (954) — (954) 2,949 — 2,949 Amounts reclassified from accumulated other comprehensive (loss) gain (256) 110 (146) (964) 114 (850) Net current-period other comprehensive (loss) income (1,210) 110 (1,100) 1,985 114 2,099 Ending balance $ 3,504 $ (5,486) $ (1,982) $ 4,440 $ (5,118) $ (678) |
Schedule of reclassifications out of accumulated other comprehensive income | The reclassifications out of accumulated other comprehensive loss shown, net of tax and parenthesis indicating debits to net income, as of September 30, 2021 and 2020 were as follows: Details about Accumulated Other Comprehensive Loss Components Amount Reclassified from Accumulated Other Comprehensive Loss Affected Line Item Three Months Ended September 30, 2021 Three Months Ended September 30, 2020 Net unrealized gain on available for sale securities $ 48 $ 1,013 Net debt securities gains, available for sale Income tax effect (9) (213) Income tax provision Total reclassifications for the period $ 39 $ 800 Net unrecognized pension costs $ (46) $ (52) Other non-interest expense Income tax effect 9 11 Income tax provision Total reclassifications for the period $ (37) $ (41) Details about Accumulated Other Comprehensive Loss Components Amount Reclassified from Accumulated Other Comprehensive Loss Affected Line Item Nine months ended September 30, 2021 Nine months ended September 30, 2020 Net unrealized gain on available for sale securities $ 323 $ 1,220 Net debt securities gains, available for sale Income tax effect (67) (256) Income tax provision Total reclassifications for the period $ 256 $ 964 Net unrecognized pension costs $ (139) $ (144) Other non-interest expense Income tax effect 29 30 Income tax provision Total reclassifications for the period $ (110) $ (114) |
Per Share Data (Tables)
Per Share Data (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Earnings Per Share [Abstract] | |
Schedule of weighted average common shares (denominator) used in the basic and dilutive earnings per share computation | Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Weighted average common shares issued 7,544,219 7,525,561 7,539,850 7,522,803 Weighted average treasury stock shares (480,225) (480,225) (480,225) (480,225) Weighted average common shares outstanding - basic and diluted 7,063,994 7,045,336 7,059,625 7,042,578 |
Investment Securities (Tables)
Investment Securities (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of amortized cost, gross unrealized gains and losses, and fair values of equity and trading investment securities | The amortized cost, gross unrealized gains and losses, and fair values of our investment securities portfolio at September 30, 2021 and December 31, 2020 are as follows: September 30, 2021 Gross Gross Amortized Unrealized Unrealized Fair (In Thousands) Cost Gains Losses Value Available for sale (AFS): Mortgage-backed securities $ 1,765 $ 10 $ — $ 1,775 State and political securities 112,308 4,610 (444) 116,474 Other debt securities 48,251 727 (467) 48,511 Total debt securities $ 162,324 $ 5,347 $ (911) $ 166,760 Investment equity securities: Other equity securities $ 1,300 $ — $ (37) $ 1,263 Trading: Other equity securities $ 50 $ — $ (10) $ 40 December 31, 2020 Gross Gross Amortized Unrealized Unrealized Fair (In Thousands) Cost Gains Losses Value Available for sale (AFS): Mortgage-backed securities $ 2,118 $ 23 $ — $ 2,141 State and political securities 102,690 5,382 (59) 108,013 Other debt securities 51,486 828 (207) 52,107 Total debt securities $ 156,294 $ 6,233 $ (266) $ 162,261 Investment equity securities: Other equity securities $ 1,300 $ 10 $ (22) $ 1,288 Trading: Other equity securities $ 50 $ — $ (10) $ 40 |
Schedule of gross unrealized losses and fair value | The following tables show the Company’s gross unrealized losses and fair value, aggregated by investment category and length of time, that the individual debt securities have been in a continuous unrealized loss position, at September 30, 2021 and December 31, 2020. September 30, 2021 Less than Twelve Months Twelve Months or Greater Total Gross Gross Gross Fair Unrealized Fair Unrealized Fair Unrealized (In Thousands) Value Losses Value Losses Value Losses Available for sale (AFS): State and political securities $ 29,367 $ (431) $ 888 $ (13) $ 30,255 $ (444) Other debt securities 10,107 (172) 2,766 (295) 12,873 (467) Total debt securities $ 39,474 $ (603) $ 3,654 $ (308) $ 43,128 $ (911) December 31, 2020 Less than Twelve Months Twelve Months or Greater Total Gross Gross Gross Fair Unrealized Fair Unrealized Fair Unrealized (In Thousands) Value Losses Value Losses Value Losses Available for sale (AFS): State and political securities $ 12,311 $ (51) $ 900 $ (8) $ 13,211 $ (59) Other debt securities 5,964 (74) 4,429 (133) 10,393 (207) Total debt securities $ 18,275 $ (125) $ 5,329 $ (141) $ 23,604 $ (266) |
Schedule of amortized cost and fair value of debt securities by contractual maturity | The amortized cost and fair value of debt securities at September 30, 2021, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities since borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. (In Thousands) Amortized Cost Fair Value Due in one year or less $ 11,076 $ 10,828 Due after one year to five years 76,785 78,108 Due after five years to ten years 69,469 72,703 Due after ten years 4,994 5,121 Total $ 162,324 $ 166,760 |
Schedule of gross realized gains and losses | The following table represents gross realized gains and losses from the sales of debt securities available for sale: Three Months Ended September 30, Nine Months Ended September 30, (In Thousands) 2021 2020 2021 2020 Available for sale (AFS): Gross realized gains: Mortgage-backed securities $ — $ — $ — $ 83 State and political securities 1 839 1 943 Other debt securities 48 174 323 194 Total gross realized gains $ 49 $ 1,013 $ 324 $ 1,220 Gross realized losses: State and political securities $ 1 $ — $ 1 $ — Other debt securities — — — — Total gross realized losses $ 1 $ — $ 1 $ — |
Schedule of unrealized and realized gains and losses recognized in net income | The following is a summary of unrealized and realized gains and losses recognized in net income on equity securities during the three and nine months ended September 30, 2021 and 2020: Three Months Ended September 30, Nine Months Ended September 30, (In Thousands) 2021 2020 2021 2020 Net (losses) gains recognized in equity securities during the period $ (6) $ — $ (25) $ 30 Less: Net gains realized on the sale of equity securities during the period — — — — Unrealized (losses) gains recognized in equity securities held at reporting date $ (6) $ — $ (25) $ 30 Net gains and losses on trading account securities are as follows for the three and nine months ended September 30, 2021 and 2020: Three Months Ended September 30, Nine Months Ended September 30, (In Thousands) 2021 2020 2021 2020 Net gains on sale transactions $ — $ — $ — $ — Net mark-to-market (losses) gains (2) (2) 1 (16) Net (loss) gain on trading account securities $ (2) $ (2) $ 1 $ (16) |
Loans (Tables)
Loans (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Loans and Leases Receivable Disclosure [Abstract] | |
Schedule of related aging categories of loans by segment | The following table presents the related aging categories of loans, by segment, as of September 30, 2021 and December 31, 2020: September 30, 2021 Past Due Past Due 90 30 To 89 Days Or More Non- (In Thousands) Current Days & Still Accruing Accrual Total Commercial, financial, and agricultural $ 179,079 $ 147 $ — $ 422 $ 179,648 Real estate mortgage: Residential 584,765 1,709 511 940 587,925 Commercial 371,197 315 — 5,498 377,010 Construction 45,899 — — 49 45,948 Consumer automobile loans 146,094 552 17 — 146,663 Other consumer installment loans 9,363 48 326 — 9,737 1,336,397 $ 2,771 $ 854 $ 6,909 1,346,931 Net deferred loan fees and discounts 294 294 Allowance for loan losses (14,557) (14,557) Loans, net $ 1,322,134 $ 1,332,668 December 31, 2020 Past Due Past Due 90 30 To 89 Days Or More Non- (In Thousands) Current Days & Still Accruing Accrual Total Commercial, financial, and agricultural $ 163,583 $ 247 $ 48 $ 865 $ 164,743 Real estate mortgage: Residential 580,292 6,386 983 2,060 589,721 Commercial 366,363 533 150 6,142 373,188 Construction 38,587 667 — 55 39,309 Consumer automobile loans 155,472 900 31 — 156,403 Other consumer installment loans 19,485 455 — — 19,940 1,323,782 $ 9,188 $ 1,212 $ 9,122 1,343,304 Net deferred loan fees and discounts 1,023 1,023 Allowance for loan losses (13,803) (13,803) Loans, net $ 1,311,002 $ 1,330,524 |
Schedule of interest income if interest had been recorded based on the original loan agreement terms and rate of interest for non-accrual loans and interest income recognized on a cash basis for non-accrual loans | The following table presents interest income the Banks would have recorded if interest had been recorded based on the original loan agreement terms and rate of interest for non-accrual loans and interest income recognized on a cash basis for non-accrual loans for the three and nine months ended September 30, 2021 and 2020: Three Months Ended September 30, 2021 2020 (In Thousands) Interest Income That Interest Interest Income That Interest Commercial, financial, and agricultural $ 28 $ — $ 2 $ 14 Real estate mortgage: Residential 6 — 14 2 Commercial 89 — 52 — Construction — — — — Consumer automobile loans — — — — Other consumer installment loans — — — — $ 123 $ — $ 68 $ 16 Nine Months Ended September 30, 2021 2020 (In Thousands) Interest Income That Interest Interest Income That Interest Commercial, financial, and agricultural $ 84 $ — $ 37 $ 14 Real estate mortgage: Residential 22 — 27 2 Commercial 144 — 116 — Construction 2 — 1 — Consumer automobile loans — — 2 3 Other consumer installment loans — — 3 — $ 252 $ — $ 186 $ 19 |
Schedule of recorded investment, unpaid principal balance, and related allowance of impaired loans by segment | The following table presents the recorded investment, unpaid principal balance, and related allowance of impaired loans by segment as of September 30, 2021 and December 31, 2020: September 30, 2021 Recorded Unpaid Principal Related (In Thousands) Investment Balance Allowance With no related allowance recorded: Commercial, financial, and agricultural $ 1,265 $ 1,265 $ — Real estate mortgage: Residential 4,003 4,003 — Commercial 3,919 3,919 — Construction 114 114 — Consumer automobile loans — — — Installment loans to individuals — — — 9,301 9,301 — With an allowance recorded: Commercial, financial, and agricultural 420 3,207 2 Real estate mortgage: Residential 1,273 1,273 246 Commercial 6,366 6,366 902 Construction — — — Consumer automobile loans — — — Installment loans to individuals 20 20 20 8,079 10,866 1,170 Total: Commercial, financial, and agricultural 1,685 4,472 2 Real estate mortgage: Residential 5,276 5,276 246 Commercial 10,285 10,285 902 Construction 114 114 — Consumer automobile loans — — — Installment loans to individuals 20 20 20 $ 17,380 $ 20,167 $ 1,170 December 31, 2020 Recorded Unpaid Principal Related (In Thousands) Investment Balance Allowance With no related allowance recorded: Commercial, financial, and agricultural $ 865 $ 3,652 $ — Real estate mortgage: Residential 5,023 5,023 — Commercial 6,354 6,354 — Construction 124 124 — Consumer automobile loans — — — Installment loans to individuals — — — 12,366 15,153 — With an allowance recorded: Commercial, financial, and agricultural — — — Real estate mortgage: Residential 1,294 1,294 224 Commercial 3,023 3,023 811 Construction — — — Consumer automobile loans — — — Installment loans to individuals — — — 4,317 4,317 1,035 Total: Commercial, financial, and agricultural 865 3,652 — Real estate mortgage: Residential 6,317 6,317 224 Commercial 9,377 9,377 811 Construction 124 124 — Consumer automobile loans — — — Installment loans to individuals — — — $ 16,683 $ 19,470 $ 1,035 |
Schedule of average recorded investment in impaired loans and related interest income recognized | The following table presents the average recorded investment in impaired loans and related interest income recognized for the three and nine months ended September 30, 2021 and 2020: Three Months Ended September 30, 2021 2020 (In Thousands) Average Interest Income Interest Income Average Interest Income Interest Income Commercial, financial, and agricultural $ 2,052 $ 13 $ — $ 1,543 $ 33 $ 14 Real estate mortgage: Residential 5,218 53 — 5,117 63 2 Commercial 10,530 61 — 6,587 71 — Construction 115 1 — 54 1 — Consumer automobile — — — 147 — — Other consumer installment loans 20 — — — — — $ 17,935 $ 128 $ — $ 13,448 $ 168 $ 16 Nine Months Ended September 30, 2021 2020 (In Thousands) Average Interest Income Interest Income Average Interest Income Interest Income Commercial, financial, and agricultural $ 1,458 $ 43 $ — $ 1,849 $ 34 $ 14 Real estate mortgage: Residential 5,650 151 — 5,535 177 2 Commercial 9,848 126 — 7,577 118 — Construction 119 4 — 60 1 — Consumer automobile 38 — — 111 1 3 Other consumer installment loans 10 9 — 4 — — $ 17,123 $ 333 $ — $ 15,136 $ 331 $ 19 |
Schedule of Loan Modifications that are Considered TDRs | Loan modifications that are considered TDRs completed during the three and nine months ended September 30, 2021 were as follows: Three Months Ended September 30, 2021 (In Thousands, Except Number of Contracts) Number Pre-Modification Outstanding Recorded Investment Post-Modification Outstanding Recorded Investment Commercial, financial, and agricultural — $ — $ — Real estate mortgage: Residential — — — Commercial — — — Construction — — — — $ — $ — Nine Months Ended September 30, 2021 (In Thousands, Except Number of Contracts) Number Pre-Modification Post-Modification Commercial, financial, and agricultural 1 $ 949 $ 949 Real estate mortgage: Residential 2 865 865 Commercial 2 855 855 Construction — — — 5 $ 2,669 $ 2,669 |
Schedule of credit quality categories | The following table presents the credit quality categories identified above as of September 30, 2021 and December 31, 2020: September 30, 2021 Commercial, Financial, and Agricultural Real Estate Mortgages Consumer automobile Other consumer installment loans (In Thousands) Residential Commercial Construction Totals Pass $ 176,189 $ 584,538 $ 360,033 $ 45,144 $ 146,663 $ 9,718 $ 1,322,285 Special Mention 442 240 6,160 686 — — 7,528 Substandard 3,017 3,147 10,817 118 — 19 17,118 $ 179,648 $ 587,925 $ 377,010 $ 45,948 $ 146,663 $ 9,737 $ 1,346,931 December 31, 2020 Commercial, Financial, and Agricultural Real Estate Mortgages Consumer automobile Other consumer installment loans (In Thousands) Residential Commercial Construction Totals Pass $ 162,694 $ 584,599 $ 355,616 $ 39,192 $ 156,403 $ 19,938 $ 1,318,442 Special Mention 180 556 7,973 — — — 8,709 Substandard 1,869 4,566 9,599 117 — 2 16,153 $ 164,743 $ 589,721 $ 373,188 $ 39,309 $ 156,403 $ 19,940 $ 1,343,304 |
Schedule of activity in the allowance | Activity in the allowance is presented for the three and nine months ended September 30, 2021 and 2020: Three Months Ended September 30, 2021 Commercial, Financial, and Agricultural Real Estate Mortgages Consumer automobile Other consumer installment (In Thousands) Residential Commercial Construction Unallocated Totals Beginning Balance $ 1,846 $ 4,619 $ 4,436 $ 212 $ 1,824 $ 44 $ 1,457 $ 14,438 Charge-offs (10) (29) — — (12) (116) — (167) Recoveries 8 — 84 5 107 7 — 211 Provision 277 175 (500) 11 (226) 194 144 75 Ending Balance $ 2,121 $ 4,765 $ 4,020 $ 228 $ 1,693 $ 129 $ 1,601 $ 14,557 Three Months Ended September 30, 2020 Commercial, Financial, and Agricultural Real Estate Mortgages Consumer automobile Other consumer installment (In Thousands) Residential Commercial Construction Unallocated Totals Beginning Balance $ 1,953 $ 4,478 $ 3,335 $ 150 $ 2,214 $ 127 $ 720 $ 12,977 Charge-offs — (6) — — (200) (33) — (239) Recoveries 9 1 — — 10 26 — 46 Provision 17 (24) (290) 20 (27) 135 814 645 Ending Balance $ 1,979 $ 4,449 $ 3,045 $ 170 $ 1,997 $ 255 $ 1,534 $ 13,429 t Nine Months Ended September 30, 2021 Commercial, Financial, and Agricultural Real Estate Mortgages Consumer automobile Other consumer installment (In Thousands) Residential Commercial Construction Unallocated Totals Beginning Balance $ 1,936 $ 4,460 $ 3,635 $ 134 $ 1,906 $ 261 $ 1,471 $ 13,803 Charge-offs (45) (172) — — (235) (173) — (625) Recoveries 22 112 109 10 139 47 — 439 Provision 208 365 276 84 (117) (6) 130 940 Ending Balance $ 2,121 $ 4,765 $ 4,020 $ 228 $ 1,693 $ 129 $ 1,601 $ 14,557 Nine Months Ended September 30, 2020 Commercial, Financial, and Agricultural Real Estate Mortgages Consumer automobile Other consumer installment (In Thousands) Residential Commercial Construction Unallocated Totals Beginning Balance $ 1,779 $ 4,306 $ 3,210 $ 118 $ 1,780 $ 278 $ 423 $ 11,894 Charge-offs (22) (174) — — (289) (215) — (700) Recoveries 32 48 — 5 17 93 — 195 Provision 190 269 (165) 47 489 99 1,111 2,040 Ending Balance $ 1,979 $ 4,449 $ 3,045 $ 170 $ 1,997 $ 255 $ 1,534 $ 13,429 |
Schedule of concentration of loan | The Company has a concentration of the following to gross loans at September 30, 2021 and 2020: September 30, 2021 2020 Owners of residential rental properties 18.84 % 16.29 % Owners of commercial rental properties 14.03 % 12.98 % |
Schedule of allowance for loan losses and the recorded investment in loans by portfolio segment based on impairment method | The following table presents the balance in the allowance for loan losses and the recorded investment in loans by portfolio segment based on impairment method as of September 30, 2021 and December 31, 2020: September 30, 2021 Commercial, Financial, and Agricultural Real Estate Mortgages Consumer Automobile Other consumer installment Unallocated (In Thousands) Residential Commercial Construction Totals Allowance for Loan Losses: Ending allowance balance attributable to loans: Individually evaluated for impairment $ 2 $ 246 $ 902 $ — $ — $ 20 $ — $ 1,170 Collectively evaluated for impairment 2,119 4,519 3,118 228 1,693 109 1,601 13,387 Total ending allowance balance $ 2,121 $ 4,765 $ 4,020 $ 228 $ 1,693 $ 129 $ 1,601 $ 14,557 Loans: Individually evaluated for impairment $ 1,685 $ 5,276 $ 10,285 $ 114 $ — $ 20 $ 17,380 Collectively evaluated for impairment 177,963 582,649 366,725 45,834 146,663 9,717 1,329,551 Total ending loans balance $ 179,648 $ 587,925 $ 377,010 $ 45,948 $ 146,663 $ 9,737 $ 1,346,931 December 31, 2020 Commercial, Financial, and Agricultural Real Estate Mortgages Consumer Automobile Other consumer installment Unallocated (In Thousands) Residential Commercial Construction Totals Allowance for Loan Losses: Ending allowance balance attributable to loans: Individually evaluated for impairment $ — $ 224 $ 811 $ — $ — $ — $ — $ 1,035 Collectively evaluated for impairment 1,936 4,236 2,824 134 1,906 261 1,471 12,768 Total ending allowance balance $ 1,936 $ 4,460 $ 3,635 $ 134 $ 1,906 $ 261 $ 1,471 $ 13,803 Loans: Individually evaluated for impairment $ 865 $ 6,317 $ 9,377 $ 124 $ — $ — $ 16,683 Collectively evaluated for impairment 163,878 583,404 363,811 39,185 156,403 19,940 1,326,621 Total ending loans balance $ 164,743 $ 589,721 $ 373,188 $ 39,309 $ 156,403 $ 19,940 $ 1,343,304 |
Net Periodic Benefit Cost-Def_2
Net Periodic Benefit Cost-Defined Benefit Plans (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Pension and Other Postretirement Benefits Cost (Reversal of Cost) [Abstract] | |
Schedule of components of the net periodic benefit/cost of the domestic non-contributory defined benefit plan | The following sets forth the components of the net periodic benefit/cost of the domestic non-contributory defined benefit plan for the three and nine months ended September 30, 2021 and 2020, respectively: Three Months Ended September 30, Nine Months Ended September 30, (In Thousands) 2021 2020 2021 2020 Interest cost $ 127 $ 161 $ 381 $ 481 Expected return on plan assets (386) (330) (1,158) (956) Amortization of net loss 45 52 138 144 Net periodic benefit $ (214) $ (117) $ (639) $ (331) |
Off-Balance Sheet Risk (Tables)
Off-Balance Sheet Risk (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Off Balance Sheet Risk | |
Schedule of Financial instruments whose contract amounts represent credit risk | Financial instruments whose contract amounts represent credit risk are as follows at September 30, 2021 and December 31, 2020: (In Thousands) September 30, 2021 December 31, 2020 Commitments to extend credit $ 236,397 $ 198,512 Standby letters of credit 9,949 10,120 Credit exposure from the sale of assets with recourse 10,031 9,182 $ 256,377 $ 217,814 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Fair Value Disclosures [Abstract] | |
Schedule of assets reported on the balance sheet at their fair value on a recurring basis | The following table presents the assets reported on the Consolidated Balance Sheet at their fair value on a recurring basis as of September 30, 2021 and December 31, 2020, by level within the fair value hierarchy. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. September 30, 2021 (In Thousands) Level I Level II Level III Total Assets measured on a recurring basis: Investment securities, available for sale: Mortgage-backed securities $ — $ 1,775 $ — $ 1,775 State and political securities — 116,474 — 116,474 Other debt securities — 48,511 — 48,511 Investment equity securities: Other equity securities 1,263 — — 1,263 Investment securities, trading: Other equity securities 40 — — 40 December 31, 2020 (In Thousands) Level I Level II Level III Total Assets measured on a recurring basis: Investment securities, available for sale: Mortgage-backed securities $ — $ 2,141 $ — $ 2,141 State and political securities — 108,013 — 108,013 Other debt securities — 52,107 — 52,107 Investment equity securities: Other equity securities 1,288 — — 1,288 Investment securities, trading: Other equity securities 40 — — 40 |
Schedule of assets reported on the consolidated balance sheet at their fair value on a non-recurring basis | The following table presents the assets reported on the Consolidated Balance Sheet at their fair value on a non-recurring basis as of September 30, 2021 and December 31, 2020, by level within the fair value hierarchy. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. September 30, 2021 (In Thousands) Level I Level II Level III Total Assets measured on a non-recurring basis: Impaired loans $ — $ — $ 16,210 $ 16,210 Other real estate owned — — 83 83 December 31, 2020 (In Thousands) Level I Level II Level III Total Assets measured on a non-recurring basis: Impaired loans $ — $ — $ 15,648 $ 15,648 Other real estate owned — — 401 401 |
Schedule of listing of significant unobservable inputs used in the fair value measurement process for items valued utilizing level III techniques | The following tables present a listing of significant unobservable inputs used in the fair value measurement process for items valued utilizing level III techniques as of September 30, 2021 and December 31, 2020: September 30, 2021 Quantitative Information About Level III Fair Value Measurements (In Thousands) Fair Value Valuation Technique(s) Unobservable Inputs Range Weighted Average Impaired loans $ 13,826 Discounted cash flow Temporary reduction in payment amount 3% to (63)% (7)% 2,384 Appraisal of collateral (1) Appraisal adjustments (1) 0% to (30)% (15)% Other real estate owned $ 83 Appraisal of collateral (1) Appraisal adjustments (1) (20)% (20)% (1) Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. December 31, 2020 Quantitative Information About Level III Fair Value Measurements (In Thousands) Fair Value Valuation Technique(s) Unobservable Inputs Range Weighted Average Impaired loans $ 8,624 Discounted cash flow Temporary reduction in payment amount 17% to (63)% (18)% 7,024 Appraisal of collateral (1) Appraisal adjustments (1) 0% to (30)% (8)% Other real estate owned $ 401 Appraisal of collateral (1) Appraisal adjustments (1) (20)% (20)% (1) Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. |
Fair Value of Financial Instr_2
Fair Value of Financial Instruments (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Fair Value Disclosures [Abstract] | |
Schedule of fair value of financial instruments | The fair values of the Company’s financial instruments not recorded at fair value on a recurring or nonrecurring basis are as follows at September 30, 2021 and December 31, 2020: Carrying Fair Fair Value Measurements at September 30, 2021 (In Thousands) Value Value Level I Level II Level III Financial assets: Cash and cash equivalents (1) $ 281,647 $ 281,647 $ 281,647 $ — $ — Restricted investment in bank stock (1) 14,649 14,649 14,649 — — Loans held for sale (1) 3,246 3,246 3,246 — — Loans, net 1,332,668 1,340,252 — — 1,340,252 Bank-owned life insurance (1) 33,836 33,836 33,836 — — Accrued interest receivable (1) 8,529 8,529 8,529 — — Financial liabilities: Interest-bearing deposits $ 1,111,144 $ 1,114,193 $ 876,786 $ — $ 237,407 Noninterest-bearing deposits (1) 481,875 481,875 481,875 — — Short-term borrowings (1) 9,404 9,404 9,404 — — Long-term borrowings 126,007 129,392 — — 129,392 Accrued interest payable (1) 828 828 828 — — (1) The financial instrument is carried at cost at September 30, 2021, which approximate the fair value of the instruments Carrying Fair Fair Value Measurements at December 31, 2020 (In Thousands) Value Value Level I Level II Level III Financial assets: Cash and cash equivalents (1) $ 213,358 $ 213,358 $ 213,358 $ — $ — Restricted investment in bank stock (1) 15,377 15,377 15,377 — — Loans held for sale (1) 5,239 5,239 5,239 — — Loans, net 1,330,524 1,339,993 — — 1,339,993 Bank-owned life insurance (1) 33,638 33,638 33,638 — — Accrued interest receivable (1) 8,394 8,394 8,394 — — Financial liabilities: Interest-bearing deposits $ 1,045,086 $ 1,048,281 $ 781,441 $ — $ 266,840 Noninterest-bearing deposits (1) 449,357 449,357 449,357 — — Short-term borrowings (1) 5,244 5,244 5,244 — — Long-term borrowings 153,475 159,575 — — 159,575 Accrued interest payable (1) 1,112 1,112 1,112 — — (1) The financial instrument is carried at cost at December 31, 2020, which approximate the fair value of the instruments |
Stock Options (Tables)
Stock Options (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of Share-based Compensation, Stock Options Granted | Stock Options Granted Date Shares Forfeited Outstanding Strike Price Vesting Period Expiration April 9, 2021 156,500 — 156,500 $ 24.23 3 years 10 years April 9, 2021 78,000 — 78,000 24.23 5 years 10 years March 11, 2020 119,300 — 119,300 25.31 3 years 10 years March 11, 2020 119,200 — 119,200 25.31 5 years 10 years March 15, 2019 120,900 (12,900) 108,000 28.01 3 years 10 years March 15, 2019 119,100 (12,600) 106,500 28.01 5 years 10 years August 24, 2018 75,300 (9,900) 65,400 30.67 3 years 10 years August 24, 2018 149,250 (19,800) 129,450 30.67 5 years 10 years January 5, 2018 18,750 — 18,750 30.07 3 years 10 years January 5, 2018 18,750 — 18,750 30.07 5 years 10 years March 24, 2017 69,375 (11,250) 58,125 29.47 3 years 10 years March 24, 2017 35,625 (2,250) 33,375 29.47 5 years 10 years August 27, 2015 58,125 (24,000) 34,125 28.02 5 years 10 years A summary of stock option activity is presented below: September 30, 2021 September 30, 2020 Shares Weighted Average Exercise Price Shares Weighted Average Exercise Price Outstanding, beginning of year 841,275 $ 28.17 625,800 $ 29.29 Granted 234,500 24.23 238,500 25.34 Exercised — — — — Forfeited (30,300) 29.33 — — Expired — — — — Outstanding, end of period 1,045,475 $ 27.25 864,300 $ 28.20 Exercisable, end of period 176,400 $ 29.70 97,875 $ 28.95 |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Sep. 30, 2021 | |
Leases [Abstract] | |
Schedule of Assets and Liabilities | The following table shows finance lease right of use assets and finance lease liabilities as of: (In Thousands) Statement of Financial Condition classification September 30, 2021 December 31, 2020 Finance lease right of use assets Premises and equipment, net $ 7,543 $ 5,257 Finance lease liabilities Long-term borrowings 8,007 5,475 |
Schedule of Lease Cost, Term and Discount Rate | The following table shows the components of finance and operating lease expense for the three and nine months ended September 30, 2021 and 2020: Three Months Ended September 30, Nine Months Ended September 30, (In Thousands) 2021 2020 2021 2020 Finance Lease Cost: Amortization of right-of-use asset $ 108 $ 50 $ 367 $ 150 Interest expense 62 53 195 159 Operating lease cost 73 76 223 243 Variable lease cost — — — — Total Lease Cost $ 243 $ 179 $ 785 $ 552 The following table shows the weighted average remaining lease term and weighted average discount rate for both operating and finance leases outstanding as of September 30, 2021. Operating Finance Weighted-average term (years) 17.8 24.6 Weighted-average discount rate 3.52 % 3.19 % |
Schedule of Operating Lease Liability Maturities | A maturity analysis of operating and finance lease liabilities and reconciliation of the undiscounted cash flows to the total operating lease liability is as follows: (In Thousands) Operating Finance 2021 $ 71 $ 104 2022 290 420 2023 265 421 2024 255 427 2025 257 929 2026 and thereafter 2,829 9,664 Total undiscounted cash flows 3,967 11,965 Discount on cash flows (1,020) (3,958) Total lease liability $ 2,947 $ 8,007 |
Schedule of Finance Lease Liability Maturities | A maturity analysis of operating and finance lease liabilities and reconciliation of the undiscounted cash flows to the total operating lease liability is as follows: (In Thousands) Operating Finance 2021 $ 71 $ 104 2022 290 420 2023 265 421 2024 255 427 2025 257 929 2026 and thereafter 2,829 9,664 Total undiscounted cash flows 3,967 11,965 Discount on cash flows (1,020) (3,958) Total lease liability $ 2,947 $ 8,007 |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Gain (loss) - Schedule of AOCI (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Beginning balance | $ 166,835 | $ 159,608 | $ 164,146 | $ 154,982 |
Ending balance | 168,481 | 162,429 | 168,481 | 162,429 |
Total | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Beginning balance | (1,438) | (965) | (882) | (2,777) |
Other comprehensive gain (loss) before reclassifications | (542) | 1,046 | (954) | 2,949 |
Amounts reclassified from accumulated other comprehensive (loss) gain | (2) | (759) | (146) | (850) |
Net current-period other comprehensive (loss) income | (544) | 287 | (1,100) | 2,099 |
Ending balance | (1,982) | (678) | (1,982) | (678) |
Net Unrealized Gain (Loss) on Available for Sale Securities | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Beginning balance | 4,085 | 4,194 | 4,714 | 2,455 |
Other comprehensive gain (loss) before reclassifications | (542) | 1,046 | (954) | 2,949 |
Amounts reclassified from accumulated other comprehensive (loss) gain | (39) | (800) | (256) | (964) |
Net current-period other comprehensive (loss) income | (581) | 246 | (1,210) | 1,985 |
Ending balance | 3,504 | 4,440 | 3,504 | 4,440 |
Defined Benefit Plan | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Beginning balance | (5,523) | (5,159) | (5,596) | (5,232) |
Other comprehensive gain (loss) before reclassifications | 0 | 0 | 0 | 0 |
Amounts reclassified from accumulated other comprehensive (loss) gain | 37 | 41 | 110 | 114 |
Net current-period other comprehensive (loss) income | 37 | 41 | 110 | 114 |
Ending balance | $ (5,486) | $ (5,118) | $ (5,486) | $ (5,118) |
Accumulated Other Comprehensi_4
Accumulated Other Comprehensive Gain (loss) - Schedule of Reclassifications out of AOCI (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Reclassifications out of accumulated other comprehensive income | ||||
Net unrealized gain on available for sale securities | $ 48 | $ 1,013 | $ 323 | $ 1,220 |
Net unrecognized pension costs | (1,273) | (1,216) | (3,541) | (4,041) |
Income tax effect | (932) | (1,051) | (2,516) | (2,563) |
Net Income | 4,125 | 4,472 | 11,154 | 11,305 |
Amount Reclassified from Accumulated Other Comprehensive Loss | Net Unrealized Gain (Loss) on Available for Sale Securities | ||||
Reclassifications out of accumulated other comprehensive income | ||||
Net unrealized gain on available for sale securities | 48 | 1,013 | 323 | 1,220 |
Income tax effect | (9) | (213) | (67) | (256) |
Net Income | 39 | 800 | 256 | 964 |
Amount Reclassified from Accumulated Other Comprehensive Loss | Defined Benefit Plan | ||||
Reclassifications out of accumulated other comprehensive income | ||||
Net unrecognized pension costs | (46) | (52) | (139) | (144) |
Income tax effect | 9 | 11 | 29 | 30 |
Net Income | $ (37) | $ (41) | $ (110) | $ (114) |
Per Share Data - Narrative (Det
Per Share Data - Narrative (Details) - $ / shares | 3 Months Ended | 9 Months Ended | ||||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Aug. 27, 2015 | |
Earnings Per Share [Abstract] | ||||||
Convertible securities which would affect denominator in calculating basic and dilutive earnings per share (in shares) | 0 | |||||
Options, outstanding (in shares) | 1,045,475 | 864,300 | 1,045,475 | 841,275 | 625,800 | 34,125 |
Outstanding, weighted average exercise price (in dollars per share) | $ 27.25 | $ 28.20 | $ 27.25 | $ 28.17 | $ 29.29 | |
Average share price (in dollars per share) | $ 23.70 | $ 24.20 |
Per Share Data - Composition of
Per Share Data - Composition of Weighted Average Common Shares Used in Earnings per Share Computation (Details) - shares | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Earnings Per Share [Abstract] | ||||
Weighted average common shares issued (in shares) | 7,544,219 | 7,525,561 | 7,539,850 | 7,522,803 |
Weighted average treasury stock shares (in shares) | (480,225) | (480,225) | (480,225) | (480,225) |
Weighted average shares outstanding - basic (in shares) | 7,063,994 | 7,045,336 | 7,059,625 | 7,042,578 |
Weighted average common shares outstanding - diluted (in shares) | 7,063,994 | 7,045,336 | 7,059,625 | 7,042,578 |
Investment Securities - Amortiz
Investment Securities - Amortized Cost and Fair Values of Investment Securities Available for Sale (Details) - USD ($) $ in Thousands | Sep. 30, 2021 | Dec. 31, 2020 |
Available for sale (AFS): | ||
Total | $ 162,324 | |
Fair value | 166,760 | $ 162,261 |
Investment equity securities: | ||
Fair value | 1,263 | 1,288 |
Trading: | ||
Fair value | 40 | 40 |
Total debt securities | ||
Available for sale (AFS): | ||
Total | 162,324 | 156,294 |
Gross unrealized gains | 5,347 | 6,233 |
Gross unrealized losses | (911) | (266) |
Fair value | 166,760 | 162,261 |
Mortgage-backed securities | ||
Available for sale (AFS): | ||
Total | 1,765 | 2,118 |
Gross unrealized gains | 10 | 23 |
Gross unrealized losses | 0 | 0 |
Fair value | 1,775 | 2,141 |
State and political securities | ||
Available for sale (AFS): | ||
Total | 112,308 | 102,690 |
Gross unrealized gains | 4,610 | 5,382 |
Gross unrealized losses | (444) | (59) |
Fair value | 116,474 | 108,013 |
Other debt securities | ||
Available for sale (AFS): | ||
Total | 48,251 | 51,486 |
Gross unrealized gains | 727 | 828 |
Gross unrealized losses | (467) | (207) |
Fair value | 48,511 | 52,107 |
Other equity securities | ||
Investment equity securities: | ||
Amortized cost - total | 1,300 | 1,300 |
Gross unrealized gains | 0 | 10 |
Gross unrealized losses | (37) | (22) |
Fair value | 1,263 | 1,288 |
Trading: | ||
Amortized cost - total | 50 | 50 |
Gross unrealized gains | 0 | 0 |
Gross unrealized losses | (10) | (10) |
Fair value | $ 40 | $ 40 |
Investment Securities - Gross U
Investment Securities - Gross Unrealized Losses and Fair Value by Investment Category (Details) - USD ($) $ in Thousands | Sep. 30, 2021 | Dec. 31, 2020 |
Total debt securities | ||
Investment securities | ||
Fair value, less than twelve months | $ 39,474 | $ 18,275 |
Gross unrealized losses, less than twelve months | (603) | (125) |
Fair value, twelve months or greater | 3,654 | 5,329 |
Gross unrealized losses, twelve months or greater | (308) | (141) |
Fair value, total | 43,128 | 23,604 |
Gross unrealized losses, total | (911) | (266) |
State and political securities | ||
Investment securities | ||
Fair value, less than twelve months | 29,367 | 12,311 |
Gross unrealized losses, less than twelve months | (431) | (51) |
Fair value, twelve months or greater | 888 | 900 |
Gross unrealized losses, twelve months or greater | (13) | (8) |
Fair value, total | 30,255 | 13,211 |
Gross unrealized losses, total | (444) | (59) |
Other debt securities | ||
Investment securities | ||
Fair value, less than twelve months | 10,107 | 5,964 |
Gross unrealized losses, less than twelve months | (172) | (74) |
Fair value, twelve months or greater | 2,766 | 4,429 |
Gross unrealized losses, twelve months or greater | (295) | (133) |
Fair value, total | 12,873 | 10,393 |
Gross unrealized losses, total | $ (467) | $ (207) |
Investment Securities - Narrati
Investment Securities - Narrative (Details) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2021USD ($)security | Sep. 30, 2020USD ($) | Sep. 30, 2021USD ($)security | Sep. 30, 2020USD ($) | Dec. 31, 2020USD ($) | |
Investments, Debt and Equity Securities [Abstract] | |||||
Number of individual securities that were in a continuous unrealized loss position for less than twelve months (in securities) | security | 71 | 71 | |||
Number of individual securities that were in a continuous unrealized loss position for greater than twelve months (in securities) | security | 7 | 7 | |||
Gross proceeds from sales of securities | $ 13,689,000 | $ 37,252,000 | |||
Impairment charges | $ 0 | $ 0 | 0 | $ 0 | |
Carrying value of investment securities pledged | 121,299,000 | 121,299,000 | $ 111,247,000 | ||
Investment equity securities, at fair value | $ 1,263,000 | $ 1,263,000 | $ 1,288,000 |
Investment Securities - Amort_2
Investment Securities - Amortized Cost and Fair Value of Debt Securities (Details) $ in Thousands | Sep. 30, 2021USD ($) |
Amortized Cost | |
Due in one year or less | $ 11,076 |
Due after one year to five years | 76,785 |
Due after five years to ten years | 69,469 |
Due after ten years | 4,994 |
Total | 162,324 |
Fair Value | |
Due in one year or less | 10,828 |
Due after one year to five years | 78,108 |
Due after five years to ten years | 72,703 |
Due after ten years | 5,121 |
Total | $ 166,760 |
Investment Securities - Total G
Investment Securities - Total Gross Proceeds from Sales of Securities (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Available for sale (AFS): | ||||
Available-for-sale securities, gross realized gains | $ 49 | $ 1,013 | $ 324 | $ 1,220 |
Available-for-sale securities, gross realized losses | 1 | 0 | 1 | 0 |
Mortgage-backed securities | ||||
Available for sale (AFS): | ||||
Available-for-sale securities, gross realized gains | 0 | 0 | 0 | 83 |
State and political securities | ||||
Available for sale (AFS): | ||||
Available-for-sale securities, gross realized gains | 1 | 839 | 1 | 943 |
Available-for-sale securities, gross realized losses | 1 | 0 | 1 | 0 |
Other debt securities | ||||
Available for sale (AFS): | ||||
Available-for-sale securities, gross realized gains | 48 | 174 | 323 | 194 |
Available-for-sale securities, gross realized losses | $ 0 | $ 0 | $ 0 | $ 0 |
Investment Securities - Unreali
Investment Securities - Unrealized and Realized Gains and Losses Recognized in Net Income (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Equity Securities, FV-NI, Gain (Loss) [Abstract] | ||||
Net (losses) gains recognized in equity securities during the period | $ (6) | $ 0 | $ (25) | $ 30 |
Less: Net gains realized on the sale of equity securities during the period | 0 | 0 | 0 | 0 |
Unrealized (losses) gains recognized in equity securities held at reporting date | (6) | 0 | (25) | 30 |
Debt Securities, Trading, Gain (Loss) [Abstract] | ||||
Net gains on sale transactions | 0 | 0 | 0 | 0 |
Net mark-to-market (losses) gains | (2) | (2) | 1 | (16) |
Net (loss) gain on trading account securities | $ (2) | $ (2) | $ 1 | $ (16) |
Loans - Narrative (Details)
Loans - Narrative (Details) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2021USD ($)categorycontractclasscomponent | Sep. 30, 2020contract | Sep. 30, 2021USD ($)categorycontractclasscomponent | Sep. 30, 2020USD ($)contract | Dec. 31, 2020USD ($) | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Financing receivable individually evaluated for impairment minimum amount | $ 100,000 | ||||
Individually evaluated for impairment | $ 100,000 | ||||
Payment delays limit (in days) | 90 days | ||||
Period to classify TDR non performing loans to performing (in months) | 6 months | ||||
Number of loan modifications (in contracts) | contract | 0 | 0 | 5 | 0 | |
Number of TDRs that defaulted (in contracts) | contract | 2 | 2 | |||
Recorded investment | $ 12,612,000 | $ 12,612,000 | $ 12,359,000 | ||
Real estate acquired through foreclosure | 83,000 | 83,000 | 401,000 | ||
Mortgage loans in process of foreclosure, amount | $ 193,000 | $ 193,000 | $ 629,154 | ||
Number of categories considered not criticized and rated as pass (in categories) | category | 6 | 6 | |||
Minimum period after which loans are considered as substandard (in days) | 90 days | ||||
Number of components that represents the allowance for loan losses (in components) | component | 2 | 2 | |||
Number of classes that groups of loans are collectively evaluated for impairment (in classes) | class | 2 | 2 | |||
Real Estate | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Number of categories in which real estate loans segmented (in categories) | category | 3 | ||||
Jersey Shore State Bank | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Amount after which external annual loan review of commercial relationships performed, minimum | $ 1,750,000 | ||||
Commercial, financial, and agricultural | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Number of loan modifications (in contracts) | contract | 0 | 1 | |||
Number of TDRs that defaulted (in contracts) | contract | 1 | ||||
Troubled debt restructuring, default amount | $ 640,000 | ||||
Commercial | Real Estate Mortgages | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Number of loan modifications (in contracts) | contract | 0 | 2 | |||
Number of TDRs that defaulted (in contracts) | contract | 2 | 1 | |||
Troubled debt restructuring, default amount | $ 706,000 | $ 1,040,000 | |||
COVID-19 Modifications | |||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||||
Number of loan modifications (in contracts) | contract | 1,371 | ||||
Number of loan modifications remaining (in contracts) | contract | 14 | ||||
Loan modifications, amount | $ 1,346,000 | $ 1,346,000 |
Loans - Aging Categories of Loa
Loans - Aging Categories of Loans by Segment (Details) - USD ($) $ in Thousands | Sep. 30, 2021 | Jun. 30, 2021 | Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Dec. 31, 2019 |
Aging categories of loans by segment | ||||||
Loans, current and past due 30 to 89 days | $ 1,347,225 | $ 1,344,327 | ||||
Past due 90 days or more & still accruing | 854 | 1,212 | ||||
Non-accrual | 6,909 | 9,122 | ||||
Total | 1,346,931 | 1,343,304 | ||||
Net deferred loan fees and discounts | 294 | 1,023 | ||||
Allowance for loan losses | (14,557) | $ (14,438) | (13,803) | $ (13,429) | $ (12,977) | $ (11,894) |
Current loans, net | 1,322,134 | 1,311,002 | ||||
Loans, net | 1,332,668 | 1,330,524 | ||||
Current | ||||||
Aging categories of loans by segment | ||||||
Loans, current and past due 30 to 89 days | 1,336,397 | 1,323,782 | ||||
Past Due 30 to 89 Days | ||||||
Aging categories of loans by segment | ||||||
Loans, current and past due 30 to 89 days | 2,771 | 9,188 | ||||
Commercial, financial, and agricultural | ||||||
Aging categories of loans by segment | ||||||
Past due 90 days or more & still accruing | 0 | 48 | ||||
Non-accrual | 422 | 865 | ||||
Total | 179,648 | 164,743 | ||||
Allowance for loan losses | (2,121) | (1,846) | (1,936) | (1,979) | (1,953) | (1,779) |
Commercial, financial, and agricultural | Current | ||||||
Aging categories of loans by segment | ||||||
Loans, current and past due 30 to 89 days | 179,079 | 163,583 | ||||
Commercial, financial, and agricultural | Past Due 30 to 89 Days | ||||||
Aging categories of loans by segment | ||||||
Loans, current and past due 30 to 89 days | 147 | 247 | ||||
Real Estate Mortgages | Residential | ||||||
Aging categories of loans by segment | ||||||
Past due 90 days or more & still accruing | 511 | 983 | ||||
Non-accrual | 940 | 2,060 | ||||
Total | 587,925 | 589,721 | ||||
Allowance for loan losses | (4,765) | (4,619) | (4,460) | (4,449) | (4,478) | (4,306) |
Real Estate Mortgages | Residential | Current | ||||||
Aging categories of loans by segment | ||||||
Loans, current and past due 30 to 89 days | 584,765 | 580,292 | ||||
Real Estate Mortgages | Residential | Past Due 30 to 89 Days | ||||||
Aging categories of loans by segment | ||||||
Loans, current and past due 30 to 89 days | 1,709 | 6,386 | ||||
Real Estate Mortgages | Commercial | ||||||
Aging categories of loans by segment | ||||||
Past due 90 days or more & still accruing | 0 | 150 | ||||
Non-accrual | 5,498 | 6,142 | ||||
Total | 377,010 | 373,188 | ||||
Allowance for loan losses | (4,020) | (4,436) | (3,635) | (3,045) | (3,335) | (3,210) |
Real Estate Mortgages | Commercial | Current | ||||||
Aging categories of loans by segment | ||||||
Loans, current and past due 30 to 89 days | 371,197 | 366,363 | ||||
Real Estate Mortgages | Commercial | Past Due 30 to 89 Days | ||||||
Aging categories of loans by segment | ||||||
Loans, current and past due 30 to 89 days | 315 | 533 | ||||
Real Estate Mortgages | Construction | ||||||
Aging categories of loans by segment | ||||||
Past due 90 days or more & still accruing | 0 | 0 | ||||
Non-accrual | 49 | 55 | ||||
Total | 45,948 | 39,309 | ||||
Allowance for loan losses | (228) | (212) | (134) | (170) | (150) | (118) |
Real Estate Mortgages | Construction | Current | ||||||
Aging categories of loans by segment | ||||||
Loans, current and past due 30 to 89 days | 45,899 | 38,587 | ||||
Real Estate Mortgages | Construction | Past Due 30 to 89 Days | ||||||
Aging categories of loans by segment | ||||||
Loans, current and past due 30 to 89 days | 0 | 667 | ||||
Consumer automobile loans | ||||||
Aging categories of loans by segment | ||||||
Past due 90 days or more & still accruing | 17 | 31 | ||||
Non-accrual | 0 | 0 | ||||
Total | 146,663 | 156,403 | ||||
Allowance for loan losses | (1,693) | (1,824) | (1,906) | (1,997) | (2,214) | (1,780) |
Consumer automobile loans | Current | ||||||
Aging categories of loans by segment | ||||||
Loans, current and past due 30 to 89 days | 146,094 | 155,472 | ||||
Consumer automobile loans | Past Due 30 to 89 Days | ||||||
Aging categories of loans by segment | ||||||
Loans, current and past due 30 to 89 days | 552 | 900 | ||||
Other consumer installment loans | ||||||
Aging categories of loans by segment | ||||||
Past due 90 days or more & still accruing | 326 | 0 | ||||
Non-accrual | 0 | 0 | ||||
Total | 9,737 | 19,940 | ||||
Allowance for loan losses | (129) | $ (44) | (261) | $ (255) | $ (127) | $ (278) |
Other consumer installment loans | Current | ||||||
Aging categories of loans by segment | ||||||
Loans, current and past due 30 to 89 days | 9,363 | 19,485 | ||||
Other consumer installment loans | Past Due 30 to 89 Days | ||||||
Aging categories of loans by segment | ||||||
Loans, current and past due 30 to 89 days | $ 48 | $ 455 |
Loans - Interest Income (Detail
Loans - Interest Income (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Interest Income That Would Have Been Recorded Based on Original Term and Rate | $ 123 | $ 68 | $ 252 | $ 186 |
Interest Income Recorded on a Cash Basis | 0 | 16 | 0 | 19 |
Commercial, financial, and agricultural | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Interest Income That Would Have Been Recorded Based on Original Term and Rate | 28 | 2 | 84 | 37 |
Interest Income Recorded on a Cash Basis | 0 | 14 | 0 | 14 |
Real Estate Mortgages | Residential | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Interest Income That Would Have Been Recorded Based on Original Term and Rate | 6 | 14 | 22 | 27 |
Interest Income Recorded on a Cash Basis | 0 | 2 | 0 | 2 |
Real Estate Mortgages | Commercial | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Interest Income That Would Have Been Recorded Based on Original Term and Rate | 89 | 52 | 144 | 116 |
Interest Income Recorded on a Cash Basis | 0 | 0 | 0 | 0 |
Real Estate Mortgages | Construction | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Interest Income That Would Have Been Recorded Based on Original Term and Rate | 0 | 0 | 2 | 1 |
Interest Income Recorded on a Cash Basis | 0 | 0 | 0 | 0 |
Consumer automobile loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Interest Income That Would Have Been Recorded Based on Original Term and Rate | 0 | 0 | 0 | 2 |
Interest Income Recorded on a Cash Basis | 0 | 0 | 0 | 3 |
Other consumer installment loans | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Interest Income That Would Have Been Recorded Based on Original Term and Rate | 0 | 0 | 0 | 3 |
Interest Income Recorded on a Cash Basis | $ 0 | $ 0 | $ 0 | $ 0 |
Loans - Recorded Investment, Un
Loans - Recorded Investment, Unpaid Principal Balance, Related Allowance of Impaired Loans (Details) - USD ($) $ in Thousands | Sep. 30, 2021 | Dec. 31, 2020 |
Credit Quality and Related Allowance for Loan Losses | ||
Recorded investment, with no related allowance recorded | $ 9,301 | $ 12,366 |
Recorded investment, with an allowance recorded | 8,079 | 4,317 |
Recorded investment | 17,380 | 16,683 |
Unpaid principal balance, with no related allowance recorded | 9,301 | 15,153 |
Unpaid principal balance, with an allowance recorded | 10,866 | 4,317 |
Unpaid principal balance | 20,167 | 19,470 |
Related allowance | 1,170 | 1,035 |
Commercial, financial, and agricultural | ||
Credit Quality and Related Allowance for Loan Losses | ||
Recorded investment, with no related allowance recorded | 1,265 | 865 |
Recorded investment, with an allowance recorded | 420 | 0 |
Recorded investment | 1,685 | 865 |
Unpaid principal balance, with no related allowance recorded | 1,265 | 3,652 |
Unpaid principal balance, with an allowance recorded | 3,207 | 0 |
Unpaid principal balance | 4,472 | 3,652 |
Related allowance | 2 | 0 |
Real Estate Mortgages | Residential | ||
Credit Quality and Related Allowance for Loan Losses | ||
Recorded investment, with no related allowance recorded | 4,003 | 5,023 |
Recorded investment, with an allowance recorded | 1,273 | 1,294 |
Recorded investment | 5,276 | 6,317 |
Unpaid principal balance, with no related allowance recorded | 4,003 | 5,023 |
Unpaid principal balance, with an allowance recorded | 1,273 | 1,294 |
Unpaid principal balance | 5,276 | 6,317 |
Related allowance | 246 | 224 |
Real Estate Mortgages | Commercial | ||
Credit Quality and Related Allowance for Loan Losses | ||
Recorded investment, with no related allowance recorded | 3,919 | 6,354 |
Recorded investment, with an allowance recorded | 6,366 | 3,023 |
Recorded investment | 10,285 | 9,377 |
Unpaid principal balance, with no related allowance recorded | 3,919 | 6,354 |
Unpaid principal balance, with an allowance recorded | 6,366 | 3,023 |
Unpaid principal balance | 10,285 | 9,377 |
Related allowance | 902 | 811 |
Real Estate Mortgages | Construction | ||
Credit Quality and Related Allowance for Loan Losses | ||
Recorded investment, with no related allowance recorded | 114 | 124 |
Recorded investment, with an allowance recorded | 0 | 0 |
Recorded investment | 114 | 124 |
Unpaid principal balance, with no related allowance recorded | 114 | 124 |
Unpaid principal balance, with an allowance recorded | 0 | 0 |
Unpaid principal balance | 114 | 124 |
Related allowance | 0 | 0 |
Consumer automobile loans | ||
Credit Quality and Related Allowance for Loan Losses | ||
Recorded investment, with no related allowance recorded | 0 | 0 |
Recorded investment, with an allowance recorded | 0 | 0 |
Recorded investment | 0 | 0 |
Unpaid principal balance, with no related allowance recorded | 0 | 0 |
Unpaid principal balance, with an allowance recorded | 0 | 0 |
Unpaid principal balance | 0 | 0 |
Related allowance | 0 | 0 |
Installment loans to individuals | ||
Credit Quality and Related Allowance for Loan Losses | ||
Recorded investment, with no related allowance recorded | 0 | 0 |
Recorded investment, with an allowance recorded | 20 | 0 |
Recorded investment | 20 | 0 |
Unpaid principal balance, with no related allowance recorded | 0 | 0 |
Unpaid principal balance, with an allowance recorded | 20 | 0 |
Unpaid principal balance | 20 | 0 |
Related allowance | $ 20 | $ 0 |
Loans - Average Recorded Invest
Loans - Average Recorded Investment - Impaired Loans (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Credit Quality and Related Allowance for Loan Losses | ||||
Average Investment in Impaired Loans | $ 17,935 | $ 13,448 | $ 17,123 | $ 15,136 |
Interest Income Recognized on an Accrual Basis on Impaired Loans | 128 | 168 | 333 | 331 |
Interest Income Recognized on a Cash Basis on Impaired Loans | 0 | 16 | 0 | 19 |
Commercial, financial, and agricultural | ||||
Credit Quality and Related Allowance for Loan Losses | ||||
Average Investment in Impaired Loans | 2,052 | 1,543 | 1,458 | 1,849 |
Interest Income Recognized on an Accrual Basis on Impaired Loans | 13 | 33 | 43 | 34 |
Interest Income Recognized on a Cash Basis on Impaired Loans | 0 | 14 | 0 | 14 |
Real Estate Mortgages | Residential | ||||
Credit Quality and Related Allowance for Loan Losses | ||||
Average Investment in Impaired Loans | 5,218 | 5,117 | 5,650 | 5,535 |
Interest Income Recognized on an Accrual Basis on Impaired Loans | 53 | 63 | 151 | 177 |
Interest Income Recognized on a Cash Basis on Impaired Loans | 0 | 2 | 0 | 2 |
Real Estate Mortgages | Commercial | ||||
Credit Quality and Related Allowance for Loan Losses | ||||
Average Investment in Impaired Loans | 10,530 | 6,587 | 9,848 | 7,577 |
Interest Income Recognized on an Accrual Basis on Impaired Loans | 61 | 71 | 126 | 118 |
Interest Income Recognized on a Cash Basis on Impaired Loans | 0 | 0 | 0 | 0 |
Real Estate Mortgages | Construction | ||||
Credit Quality and Related Allowance for Loan Losses | ||||
Average Investment in Impaired Loans | 115 | 54 | 119 | 60 |
Interest Income Recognized on an Accrual Basis on Impaired Loans | 1 | 1 | 4 | 1 |
Interest Income Recognized on a Cash Basis on Impaired Loans | 0 | 0 | 0 | 0 |
Consumer automobile loans | ||||
Credit Quality and Related Allowance for Loan Losses | ||||
Average Investment in Impaired Loans | 0 | 147 | 38 | 111 |
Interest Income Recognized on an Accrual Basis on Impaired Loans | 0 | 0 | 0 | 1 |
Interest Income Recognized on a Cash Basis on Impaired Loans | 0 | 0 | 0 | 3 |
Other consumer installment loans | ||||
Credit Quality and Related Allowance for Loan Losses | ||||
Average Investment in Impaired Loans | 20 | 0 | 10 | 4 |
Interest Income Recognized on an Accrual Basis on Impaired Loans | 0 | 0 | 9 | 0 |
Interest Income Recognized on a Cash Basis on Impaired Loans | $ 0 | $ 0 | $ 0 | $ 0 |
Loans - Loan Modifications (Det
Loans - Loan Modifications (Details) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021USD ($)contract | Sep. 30, 2020contract | Sep. 30, 2021USD ($)contract | Sep. 30, 2020contract | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Number of contracts (in contracts) | contract | 0 | 0 | 5 | 0 |
Pre-Modification Outstanding Recorded Investment | $ 0 | $ 2,669 | ||
Post-Modification Outstanding Recorded Investment | $ 0 | $ 2,669 | ||
Commercial, financial, and agricultural | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Number of contracts (in contracts) | contract | 0 | 1 | ||
Pre-Modification Outstanding Recorded Investment | $ 0 | $ 949 | ||
Post-Modification Outstanding Recorded Investment | $ 0 | $ 949 | ||
Real Estate Mortgages | Residential | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Number of contracts (in contracts) | contract | 0 | 2 | ||
Pre-Modification Outstanding Recorded Investment | $ 0 | $ 865 | ||
Post-Modification Outstanding Recorded Investment | $ 0 | $ 865 | ||
Real Estate Mortgages | Commercial | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Number of contracts (in contracts) | contract | 0 | 2 | ||
Pre-Modification Outstanding Recorded Investment | $ 0 | $ 855 | ||
Post-Modification Outstanding Recorded Investment | $ 0 | $ 855 | ||
Real Estate Mortgages | Construction | ||||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||||
Number of contracts (in contracts) | contract | 0 | 0 | ||
Pre-Modification Outstanding Recorded Investment | $ 0 | $ 0 | ||
Post-Modification Outstanding Recorded Investment | $ 0 | $ 0 |
Loans - Credit Quality Indicato
Loans - Credit Quality Indicators (Details) - USD ($) $ in Thousands | Sep. 30, 2021 | Dec. 31, 2020 |
Credit quality categories | ||
Total | $ 1,346,931 | $ 1,343,304 |
Pass | ||
Credit quality categories | ||
Total | 1,322,285 | 1,318,442 |
Special Mention | ||
Credit quality categories | ||
Total | 7,528 | 8,709 |
Substandard | ||
Credit quality categories | ||
Total | 17,118 | 16,153 |
Commercial, financial, and agricultural | ||
Credit quality categories | ||
Total | 179,648 | 164,743 |
Commercial, financial, and agricultural | Pass | ||
Credit quality categories | ||
Total | 176,189 | 162,694 |
Commercial, financial, and agricultural | Special Mention | ||
Credit quality categories | ||
Total | 442 | 180 |
Commercial, financial, and agricultural | Substandard | ||
Credit quality categories | ||
Total | 3,017 | 1,869 |
Consumer automobile | ||
Credit quality categories | ||
Total | 146,663 | 156,403 |
Consumer automobile | Pass | ||
Credit quality categories | ||
Total | 146,663 | 156,403 |
Consumer automobile | Special Mention | ||
Credit quality categories | ||
Total | 0 | 0 |
Consumer automobile | Substandard | ||
Credit quality categories | ||
Total | 0 | 0 |
Other consumer installment loans | ||
Credit quality categories | ||
Total | 9,737 | 19,940 |
Other consumer installment loans | Pass | ||
Credit quality categories | ||
Total | 9,718 | 19,938 |
Other consumer installment loans | Special Mention | ||
Credit quality categories | ||
Total | 0 | 0 |
Other consumer installment loans | Substandard | ||
Credit quality categories | ||
Total | 19 | 2 |
Residential | Real Estate Mortgages | ||
Credit quality categories | ||
Total | 587,925 | 589,721 |
Residential | Real Estate Mortgages | Pass | ||
Credit quality categories | ||
Total | 584,538 | 584,599 |
Residential | Real Estate Mortgages | Special Mention | ||
Credit quality categories | ||
Total | 240 | 556 |
Residential | Real Estate Mortgages | Substandard | ||
Credit quality categories | ||
Total | 3,147 | 4,566 |
Commercial | Real Estate Mortgages | ||
Credit quality categories | ||
Total | 377,010 | 373,188 |
Commercial | Real Estate Mortgages | Pass | ||
Credit quality categories | ||
Total | 360,033 | 355,616 |
Commercial | Real Estate Mortgages | Special Mention | ||
Credit quality categories | ||
Total | 6,160 | 7,973 |
Commercial | Real Estate Mortgages | Substandard | ||
Credit quality categories | ||
Total | 10,817 | 9,599 |
Construction | Real Estate Mortgages | ||
Credit quality categories | ||
Total | 45,948 | 39,309 |
Construction | Real Estate Mortgages | Pass | ||
Credit quality categories | ||
Total | 45,144 | 39,192 |
Construction | Real Estate Mortgages | Special Mention | ||
Credit quality categories | ||
Total | 686 | 0 |
Construction | Real Estate Mortgages | Substandard | ||
Credit quality categories | ||
Total | $ 118 | $ 117 |
Loans - Allowance for Credit Lo
Loans - Allowance for Credit Losses on Financing Receivables (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Allowance for Loan Losses: | ||||
Beginning Balance | $ 14,438 | $ 12,977 | $ 13,803 | $ 11,894 |
Charge-offs | (167) | (239) | (625) | (700) |
Recoveries | 211 | 46 | 439 | 195 |
Provision | 75 | 645 | 940 | 2,040 |
Ending Balance | 14,557 | 13,429 | 14,557 | 13,429 |
Commercial, financial, and agricultural | ||||
Allowance for Loan Losses: | ||||
Beginning Balance | 1,846 | 1,953 | 1,936 | 1,779 |
Charge-offs | (10) | 0 | (45) | (22) |
Recoveries | 8 | 9 | 22 | 32 |
Provision | 277 | 17 | 208 | 190 |
Ending Balance | 2,121 | 1,979 | 2,121 | 1,979 |
Real Estate Mortgages | Residential | ||||
Allowance for Loan Losses: | ||||
Beginning Balance | 4,619 | 4,478 | 4,460 | 4,306 |
Charge-offs | (29) | (6) | (172) | (174) |
Recoveries | 0 | 1 | 112 | 48 |
Provision | 175 | (24) | 365 | 269 |
Ending Balance | 4,765 | 4,449 | 4,765 | 4,449 |
Real Estate Mortgages | Commercial | ||||
Allowance for Loan Losses: | ||||
Beginning Balance | 4,436 | 3,335 | 3,635 | 3,210 |
Charge-offs | 0 | 0 | 0 | 0 |
Recoveries | 84 | 0 | 109 | 0 |
Provision | (500) | (290) | 276 | (165) |
Ending Balance | 4,020 | 3,045 | 4,020 | 3,045 |
Real Estate Mortgages | Construction | ||||
Allowance for Loan Losses: | ||||
Beginning Balance | 212 | 150 | 134 | 118 |
Charge-offs | 0 | 0 | 0 | 0 |
Recoveries | 5 | 0 | 10 | 5 |
Provision | 11 | 20 | 84 | 47 |
Ending Balance | 228 | 170 | 228 | 170 |
Consumer automobile loans | ||||
Allowance for Loan Losses: | ||||
Beginning Balance | 1,824 | 2,214 | 1,906 | 1,780 |
Charge-offs | (12) | (200) | (235) | (289) |
Recoveries | 107 | 10 | 139 | 17 |
Provision | (226) | (27) | (117) | 489 |
Ending Balance | 1,693 | 1,997 | 1,693 | 1,997 |
Other consumer installment loans | ||||
Allowance for Loan Losses: | ||||
Beginning Balance | 44 | 127 | 261 | 278 |
Charge-offs | (116) | (33) | (173) | (215) |
Recoveries | 7 | 26 | 47 | 93 |
Provision | 194 | 135 | (6) | 99 |
Ending Balance | 129 | 255 | 129 | 255 |
Unallocated | ||||
Allowance for Loan Losses: | ||||
Beginning Balance | 1,457 | 720 | 1,471 | 423 |
Charge-offs | 0 | 0 | 0 | 0 |
Recoveries | 0 | 0 | 0 | 0 |
Provision | 144 | 814 | 130 | 1,111 |
Ending Balance | $ 1,601 | $ 1,534 | $ 1,601 | $ 1,534 |
Loans - Schedule of Concentrati
Loans - Schedule of Concentration Risk (Details) - Owners of rental properties - Financing receivable | 9 Months Ended | |
Sep. 30, 2021 | Sep. 30, 2020 | |
Residential | ||
Concentration Risk [Line Items] | ||
Concentration of loans (as a percent) | 18.84% | 16.29% |
Commercial | ||
Concentration Risk [Line Items] | ||
Concentration of loans (as a percent) | 14.03% | 12.98% |
Loans - Allowance for Loan Loss
Loans - Allowance for Loan Losses (Details) - USD ($) $ in Thousands | Sep. 30, 2021 | Jun. 30, 2021 | Dec. 31, 2020 | Sep. 30, 2020 | Jun. 30, 2020 | Dec. 31, 2019 |
Ending allowance balance attributable to loans: | ||||||
Individually evaluated for impairment | $ 1,170 | $ 1,035 | ||||
Collectively evaluated for impairment | 13,387 | 12,768 | ||||
Total ending allowance balance | 14,557 | $ 14,438 | 13,803 | $ 13,429 | $ 12,977 | $ 11,894 |
Loans: | ||||||
Individually evaluated for impairment | 17,380 | 16,683 | ||||
Collectively evaluated for impairment | 1,329,551 | 1,326,621 | ||||
Total | 1,346,931 | 1,343,304 | ||||
Commercial, financial, and agricultural | ||||||
Ending allowance balance attributable to loans: | ||||||
Individually evaluated for impairment | 2 | 0 | ||||
Collectively evaluated for impairment | 2,119 | 1,936 | ||||
Total ending allowance balance | 2,121 | 1,846 | 1,936 | 1,979 | 1,953 | 1,779 |
Loans: | ||||||
Individually evaluated for impairment | 1,685 | 865 | ||||
Collectively evaluated for impairment | 177,963 | 163,878 | ||||
Total | 179,648 | 164,743 | ||||
Real Estate Mortgages | Residential | ||||||
Ending allowance balance attributable to loans: | ||||||
Individually evaluated for impairment | 246 | 224 | ||||
Collectively evaluated for impairment | 4,519 | 4,236 | ||||
Total ending allowance balance | 4,765 | 4,619 | 4,460 | 4,449 | 4,478 | 4,306 |
Loans: | ||||||
Individually evaluated for impairment | 5,276 | 6,317 | ||||
Collectively evaluated for impairment | 582,649 | 583,404 | ||||
Total | 587,925 | 589,721 | ||||
Real Estate Mortgages | Commercial | ||||||
Ending allowance balance attributable to loans: | ||||||
Individually evaluated for impairment | 902 | 811 | ||||
Collectively evaluated for impairment | 3,118 | 2,824 | ||||
Total ending allowance balance | 4,020 | 4,436 | 3,635 | 3,045 | 3,335 | 3,210 |
Loans: | ||||||
Individually evaluated for impairment | 10,285 | 9,377 | ||||
Collectively evaluated for impairment | 366,725 | 363,811 | ||||
Total | 377,010 | 373,188 | ||||
Real Estate Mortgages | Construction | ||||||
Ending allowance balance attributable to loans: | ||||||
Individually evaluated for impairment | 0 | 0 | ||||
Collectively evaluated for impairment | 228 | 134 | ||||
Total ending allowance balance | 228 | 212 | 134 | 170 | 150 | 118 |
Loans: | ||||||
Individually evaluated for impairment | 114 | 124 | ||||
Collectively evaluated for impairment | 45,834 | 39,185 | ||||
Total | 45,948 | 39,309 | ||||
Consumer automobile loans | ||||||
Ending allowance balance attributable to loans: | ||||||
Individually evaluated for impairment | 0 | 0 | ||||
Collectively evaluated for impairment | 1,693 | 1,906 | ||||
Total ending allowance balance | 1,693 | 1,824 | 1,906 | 1,997 | 2,214 | 1,780 |
Loans: | ||||||
Individually evaluated for impairment | 0 | 0 | ||||
Collectively evaluated for impairment | 146,663 | 156,403 | ||||
Total | 146,663 | 156,403 | ||||
Other consumer installment loans | ||||||
Ending allowance balance attributable to loans: | ||||||
Individually evaluated for impairment | 20 | 0 | ||||
Collectively evaluated for impairment | 109 | 261 | ||||
Total ending allowance balance | 129 | 44 | 261 | 255 | 127 | 278 |
Loans: | ||||||
Individually evaluated for impairment | 20 | 0 | ||||
Collectively evaluated for impairment | 9,717 | 19,940 | ||||
Total | 9,737 | 19,940 | ||||
Unallocated | ||||||
Ending allowance balance attributable to loans: | ||||||
Individually evaluated for impairment | 0 | 0 | ||||
Collectively evaluated for impairment | 1,601 | 1,471 | ||||
Total ending allowance balance | $ 1,601 | $ 1,457 | $ 1,471 | $ 1,534 | $ 720 | $ 423 |
Net Periodic Benefit Cost-Def_3
Net Periodic Benefit Cost-Defined Benefit Plans (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | Dec. 31, 2020 | |
Net periodic benefit cost of the domestic non-contributory defined benefit plan | |||||
Interest cost | $ 127,000 | $ 161,000 | $ 381,000 | $ 481,000 | |
Expected return on plan assets | (386,000) | (330,000) | (1,158,000) | (956,000) | |
Amortization of net loss | 45,000 | 52,000 | 138,000 | 144,000 | |
Net periodic benefit | (214,000) | $ (117,000) | (639,000) | $ (331,000) | |
Expected contribution to Pension Plan (minimum) | $ 500,000 | ||||
Employer contributions made to the defined benefit plan | 600,000 | ||||
Anticipated additional contributions anticipated during the remainder of the year (at least) | $ 100,000 | $ 100,000 |
Employee Stock Purchase Plan (D
Employee Stock Purchase Plan (Details) - Employee Stock - USD ($) | 9 Months Ended | |
Sep. 30, 2021 | Sep. 30, 2020 | |
Employee Stock Purchase Plan | ||
Number of shares allowed to be purchased by employees (in shares) | 1,500,000 | |
Purchase price of the shares with respect to market value (as a percent) | 95.00% | |
Maximum percentage of base compensation | 15.00% | |
Maximum market value | $ 12,000 | |
Number of shares issued under the plan (in shares) | 2,873 | 2,888 |
Off-Balance Sheet Risk (Details
Off-Balance Sheet Risk (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2021 | Dec. 31, 2020 | |
Off Balance Sheet Risk | ||
Contract amounts representing credit risk | $ 256,377 | $ 217,814 |
Commitments to extend credit | ||
Off Balance Sheet Risk | ||
Contract amounts representing credit risk | 236,397 | 198,512 |
Standby letters of credit | ||
Off Balance Sheet Risk | ||
Contract amounts representing credit risk | $ 9,949 | 10,120 |
Coverage period for instrument (in years) | 1 year | |
Credit exposure from the sale of assets with recourse | ||
Off Balance Sheet Risk | ||
Contract amounts representing credit risk | $ 10,031 | $ 9,182 |
Fair Value Measurements - Recur
Fair Value Measurements - Recurring Assets (Details) - Recurring - USD ($) $ in Thousands | Sep. 30, 2021 | Dec. 31, 2020 |
Mortgage-backed securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | $ 1,775 | $ 2,141 |
State and political securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 116,474 | 108,013 |
Other debt securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 48,511 | 52,107 |
Other equity securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 1,263 | 1,288 |
Other equity securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 40 | 40 |
Level I | Mortgage-backed securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 0 | 0 |
Level I | State and political securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 0 | 0 |
Level I | Other debt securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 0 | 0 |
Level I | Other equity securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 1,263 | 1,288 |
Level I | Other equity securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 40 | 40 |
Level II | Mortgage-backed securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 1,775 | 2,141 |
Level II | State and political securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 116,474 | 108,013 |
Level II | Other debt securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 48,511 | 52,107 |
Level II | Other equity securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 0 | 0 |
Level II | Other equity securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 0 | 0 |
Level III | Mortgage-backed securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 0 | 0 |
Level III | State and political securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 0 | 0 |
Level III | Other debt securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 0 | 0 |
Level III | Other equity securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 0 | 0 |
Level III | Other equity securities | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | $ 0 | $ 0 |
Fair Value Measurements - Non-R
Fair Value Measurements - Non-Recurring Assets (Details) - Nonrecurring - USD ($) $ in Thousands | Sep. 30, 2021 | Dec. 31, 2020 |
Impaired loans | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | $ 16,210 | $ 15,648 |
Impaired loans | Level I | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 0 | 0 |
Impaired loans | Level II | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 0 | 0 |
Impaired loans | Level III | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 16,210 | 15,648 |
Other real estate owned | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 83 | 401 |
Other real estate owned | Level I | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 0 | 0 |
Other real estate owned | Level II | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | 0 | 0 |
Other real estate owned | Level III | ||
Fair Value Measurements [Abstract] | ||
Total assets, fair value | $ 83 | $ 401 |
Fair Value Measurements - Signi
Fair Value Measurements - Significant Unobservable Inputs (Details) - Nonrecurring - Level III $ in Thousands | Sep. 30, 2021USD ($) | Dec. 31, 2020USD ($) |
Discounted cash flow | ||
Listing of significant unobservable inputs used in the fair value measurement process for items valued utilizing level III techniques | ||
Impaired loans, fair value | $ 13,826 | $ 8,624 |
Appraisal of collateral | ||
Listing of significant unobservable inputs used in the fair value measurement process for items valued utilizing level III techniques | ||
Impaired loans, fair value | 2,384 | 7,024 |
Other real estate owned, fair value | $ 83 | $ 401 |
Measurement input, temporary reduction In payment | Discounted cash flow | Minimum | ||
Listing of significant unobservable inputs used in the fair value measurement process for items valued utilizing level III techniques | ||
Impaired loans, measurement input percentage | 0.03 | 0.17 |
Measurement input, temporary reduction In payment | Discounted cash flow | Maximum | ||
Listing of significant unobservable inputs used in the fair value measurement process for items valued utilizing level III techniques | ||
Impaired loans, measurement input percentage | (0.63) | (0.63) |
Measurement input, temporary reduction In payment | Discounted cash flow | Weighted Average | ||
Listing of significant unobservable inputs used in the fair value measurement process for items valued utilizing level III techniques | ||
Impaired loans, measurement input percentage | (0.07) | (0.18) |
Measurement input, appraised value | Appraisal of collateral | ||
Listing of significant unobservable inputs used in the fair value measurement process for items valued utilizing level III techniques | ||
Other real estate owned, measurement input percentage | (0.20) | (0.20) |
Measurement input, appraised value | Appraisal of collateral | Minimum | ||
Listing of significant unobservable inputs used in the fair value measurement process for items valued utilizing level III techniques | ||
Impaired loans, measurement input percentage | 0 | 0 |
Measurement input, appraised value | Appraisal of collateral | Maximum | ||
Listing of significant unobservable inputs used in the fair value measurement process for items valued utilizing level III techniques | ||
Impaired loans, measurement input percentage | (0.30) | (0.30) |
Measurement input, appraised value | Appraisal of collateral | Weighted Average | ||
Listing of significant unobservable inputs used in the fair value measurement process for items valued utilizing level III techniques | ||
Impaired loans, measurement input percentage | (0.15) | (0.08) |
Other real estate owned, measurement input percentage | (0.20) | (0.20) |
Measurement input, default rate | ||
Listing of significant unobservable inputs used in the fair value measurement process for items valued utilizing level III techniques | ||
Impaired loans, measurement input percentage | 0 |
Fair Value of Financial Instr_3
Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands | Sep. 30, 2021 | Dec. 31, 2020 |
Financial assets: | ||
Restricted investment in bank stock | $ 14,649 | $ 15,377 |
Bank-owned life insurance | 33,836 | 33,638 |
Accrued interest receivable | 8,529 | 8,394 |
Financial liabilities: | ||
Interest-bearing deposits | 1,111,144 | 1,045,086 |
Noninterest-bearing deposits | 481,875 | 449,357 |
Level I | ||
Financial assets: | ||
Cash and cash equivalents | 281,647 | 213,358 |
Restricted investment in bank stock | 14,649 | 15,377 |
Loans held for sale | 3,246 | 5,239 |
Loans, net | 0 | 0 |
Bank-owned life insurance | 33,836 | 33,638 |
Accrued interest receivable | 8,529 | 8,394 |
Financial liabilities: | ||
Interest-bearing deposits | 876,786 | 781,441 |
Noninterest-bearing deposits | 481,875 | 449,357 |
Short-term borrowings | 9,404 | 5,244 |
Long-term borrowings | 0 | 0 |
Accrued interest payable | 828 | 1,112 |
Level II | ||
Financial assets: | ||
Cash and cash equivalents | 0 | 0 |
Restricted investment in bank stock | 0 | 0 |
Loans held for sale | 0 | 0 |
Loans, net | 0 | 0 |
Bank-owned life insurance | 0 | 0 |
Accrued interest receivable | 0 | 0 |
Financial liabilities: | ||
Interest-bearing deposits | 0 | 0 |
Noninterest-bearing deposits | 0 | 0 |
Short-term borrowings | 0 | 0 |
Long-term borrowings | 0 | 0 |
Accrued interest payable | 0 | 0 |
Level III | ||
Financial assets: | ||
Cash and cash equivalents | 0 | 0 |
Restricted investment in bank stock | 0 | 0 |
Loans held for sale | 0 | 0 |
Loans, net | 1,340,252 | 1,339,993 |
Bank-owned life insurance | 0 | 0 |
Accrued interest receivable | 0 | 0 |
Financial liabilities: | ||
Interest-bearing deposits | 237,407 | 266,840 |
Noninterest-bearing deposits | 0 | 0 |
Short-term borrowings | 0 | 0 |
Long-term borrowings | 129,392 | 159,575 |
Accrued interest payable | 0 | 0 |
Carrying Value | ||
Financial assets: | ||
Cash and cash equivalents | 281,647 | 213,358 |
Restricted investment in bank stock | 14,649 | 15,377 |
Loans held for sale | 3,246 | 5,239 |
Loans, net | 1,332,668 | 1,330,524 |
Bank-owned life insurance | 33,836 | 33,638 |
Accrued interest receivable | 8,529 | 8,394 |
Financial liabilities: | ||
Interest-bearing deposits | 1,111,144 | 1,045,086 |
Noninterest-bearing deposits | 481,875 | 449,357 |
Short-term borrowings | 9,404 | 5,244 |
Long-term borrowings | 126,007 | 153,475 |
Accrued interest payable | 828 | 1,112 |
Fair Value | ||
Financial assets: | ||
Cash and cash equivalents | 281,647 | 213,358 |
Restricted investment in bank stock | 14,649 | 15,377 |
Loans held for sale | 3,246 | 5,239 |
Loans, net | 1,340,252 | 1,339,993 |
Bank-owned life insurance | 33,836 | 33,638 |
Accrued interest receivable | 8,529 | 8,394 |
Financial liabilities: | ||
Interest-bearing deposits | 1,114,193 | 1,048,281 |
Noninterest-bearing deposits | 481,875 | 449,357 |
Short-term borrowings | 9,404 | 5,244 |
Long-term borrowings | 129,392 | 159,575 |
Accrued interest payable | $ 828 | $ 1,112 |
Stock Options - Narrative (Deta
Stock Options - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands | Apr. 09, 2021 | Mar. 11, 2020 | Mar. 15, 2019 | Aug. 24, 2018 | Jan. 05, 2018 | Mar. 24, 2017 | Aug. 27, 2015 | Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | Dec. 31, 2020 | Dec. 31, 2019 |
Employee Stock Purchase Plan | |||||||||||||
Options, outstanding (in shares) | 34,125 | 1,045,475 | 864,300 | 1,045,475 | 864,300 | 841,275 | 625,800 | ||||||
Granted (in shares) | 58,125 | 234,500 | 238,500 | ||||||||||
Granted (in dollars per share) | $ 28.02 | $ 24.23 | $ 25.34 | ||||||||||
Exercisable period (in years) | 5 years | ||||||||||||
Tranche One | |||||||||||||
Employee Stock Purchase Plan | |||||||||||||
Options, outstanding (in shares) | 156,500 | 119,300 | 108,000 | 65,400 | 18,750 | 58,125 | |||||||
Granted (in shares) | 156,500 | 119,300 | 120,900 | 75,300 | 18,750 | 69,375 | |||||||
Granted (in dollars per share) | $ 24.23 | $ 25.31 | $ 28.01 | $ 30.67 | $ 30.07 | $ 29.47 | |||||||
Exercisable period (in years) | 3 years | 3 years | 3 years | 3 years | 3 years | 3 years | |||||||
Tranche Two | |||||||||||||
Employee Stock Purchase Plan | |||||||||||||
Options, outstanding (in shares) | 78,000 | 119,200 | 106,500 | 129,450 | 18,750 | 33,375 | |||||||
Granted (in shares) | 78,000 | 119,200 | 119,100 | 149,250 | 18,750 | 35,625 | |||||||
Granted (in dollars per share) | $ 24.23 | $ 25.31 | $ 28.01 | $ 30.67 | $ 30.07 | $ 29.47 | |||||||
Exercisable period (in years) | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | |||||||
Employee Stock Option | |||||||||||||
Employee Stock Purchase Plan | |||||||||||||
Options, outstanding (in shares) | 841,275 | ||||||||||||
Exercisable period (in years) | 10 years | ||||||||||||
Compensation expense | $ 227 | $ 239 | $ 754 | $ 675 | |||||||||
Number of exercisable options (in shares) | 176,400 | 176,400 | |||||||||||
Weighted average remaining contractual term (in years) | 7 years 2 months 8 days | ||||||||||||
Unrecognized compensation cost for non-vested shares | $ 2,142 | $ 2,142 | |||||||||||
Period for recognition (in years) | 1 year 2 months 1 day | ||||||||||||
Employee Stock Option | Tranche One | |||||||||||||
Employee Stock Purchase Plan | |||||||||||||
Exercisable period (in years) | 3 years | ||||||||||||
Employee Stock Option | Tranche Two | |||||||||||||
Employee Stock Purchase Plan | |||||||||||||
Exercisable period (in years) | 5 years |
Stock Options - Schedule of Sto
Stock Options - Schedule of Stock Options Granted (Details) - $ / shares | Apr. 09, 2021 | Mar. 11, 2020 | Mar. 15, 2019 | Aug. 24, 2018 | Jan. 05, 2018 | Mar. 24, 2017 | Aug. 27, 2015 | Sep. 30, 2021 | Sep. 30, 2020 | Dec. 31, 2020 | Dec. 31, 2019 |
Employee Stock Purchase Plan | |||||||||||
Shares (in shares) | 58,125 | 234,500 | 238,500 | ||||||||
Forfeited (in shares) | (24,000) | (30,300) | 0 | ||||||||
Outstanding (in shares) | 34,125 | 1,045,475 | 864,300 | 841,275 | 625,800 | ||||||
Strike price (in dollars per share) | $ 28.02 | $ 24.23 | $ 25.34 | ||||||||
Vesting period (in years) | 5 years | ||||||||||
Expiration (in years) | 10 years | ||||||||||
Tranche One | |||||||||||
Employee Stock Purchase Plan | |||||||||||
Shares (in shares) | 156,500 | 119,300 | 120,900 | 75,300 | 18,750 | 69,375 | |||||
Forfeited (in shares) | 0 | 0 | (12,900) | (9,900) | 0 | (11,250) | |||||
Outstanding (in shares) | 156,500 | 119,300 | 108,000 | 65,400 | 18,750 | 58,125 | |||||
Strike price (in dollars per share) | $ 24.23 | $ 25.31 | $ 28.01 | $ 30.67 | $ 30.07 | $ 29.47 | |||||
Vesting period (in years) | 3 years | 3 years | 3 years | 3 years | 3 years | 3 years | |||||
Expiration (in years) | 10 years | 10 years | 10 years | 10 years | 10 years | 10 years | |||||
Tranche Two | |||||||||||
Employee Stock Purchase Plan | |||||||||||
Shares (in shares) | 78,000 | 119,200 | 119,100 | 149,250 | 18,750 | 35,625 | |||||
Forfeited (in shares) | 0 | 0 | (12,600) | (19,800) | 0 | (2,250) | |||||
Outstanding (in shares) | 78,000 | 119,200 | 106,500 | 129,450 | 18,750 | 33,375 | |||||
Strike price (in dollars per share) | $ 24.23 | $ 25.31 | $ 28.01 | $ 30.67 | $ 30.07 | $ 29.47 | |||||
Vesting period (in years) | 5 years | 5 years | 5 years | 5 years | 5 years | 5 years | |||||
Expiration (in years) | 10 years | 10 years | 10 years | 10 years | 10 years | 10 years |
Stock Options - Schedule of Opt
Stock Options - Schedule of Options Outstanding (Details) - $ / shares | Aug. 27, 2015 | Sep. 30, 2021 | Sep. 30, 2020 |
Shares | |||
Outstanding, beginning of year (in shares) | 841,275 | 625,800 | |
Granted (in shares) | 58,125 | 234,500 | 238,500 |
Exercised (in shares) | 0 | 0 | |
Forfeited (in shares) | (24,000) | (30,300) | 0 |
Expired (in shares) | 0 | 0 | |
Outstanding, end of period (in shares) | 34,125 | 1,045,475 | 864,300 |
Exercisable, end of period (in shares) | 176,400 | 97,875 | |
Weighted Average Exercise Price | |||
Outstanding, weighted average exercise price (in dollars per share) | $ 28.17 | $ 29.29 | |
Granted (in dollars per share) | $ 28.02 | 24.23 | 25.34 |
Exercised (in dollars per share) | 0 | 0 | |
Forfeited (in dollars per share) | 29.33 | 0 | |
Expired (in dollars per share) | 0 | 0 | |
Outstanding, weighted average exercise price (in dollars per share) | 27.25 | 28.20 | |
Exercisable, end of period (in dollars per share) | $ 29.70 | $ 28.95 |
Leases - Assets and Liabilities
Leases - Assets and Liabilities (Details) - USD ($) $ in Thousands | Sep. 30, 2021 | Dec. 31, 2020 |
Leases [Abstract] | ||
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] | Premises and equipment, net | Premises and equipment, net |
Finance lease right of use assets | $ 7,543 | $ 5,257 |
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration] | Long-term borrowings | Long-term borrowings |
Finance lease liabilities | $ 8,007 | $ 5,475 |
Leases - Lease Cost (Details)
Leases - Lease Cost (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2021 | Sep. 30, 2020 | Sep. 30, 2021 | Sep. 30, 2020 | |
Finance Lease Cost: | ||||
Amortization of right-of-use asset | $ 108 | $ 50 | $ 367 | $ 150 |
Interest expense | 62 | 53 | 195 | 159 |
Operating lease cost | 73 | 76 | 223 | 243 |
Variable lease cost | 0 | 0 | 0 | 0 |
Total Lease Cost | $ 243 | $ 179 | $ 785 | $ 552 |
Leases - Maturity Schedule (Det
Leases - Maturity Schedule (Details) - USD ($) $ in Thousands | Sep. 30, 2021 | Dec. 31, 2020 |
Operating | ||
2021 | $ 71 | |
2022 | 290 | |
2023 | 265 | |
2024 | 255 | |
2025 | 257 | |
2026 and thereafter | 2,829 | |
Total undiscounted cash flows | 3,967 | |
Discount on cash flows | (1,020) | |
Total lease liability | 2,947 | $ 3,175 |
Finance | ||
2021 | 104 | |
2022 | 420 | |
2023 | 421 | |
2024 | 427 | |
2025 | 929 | |
2026 and thereafter | 9,664 | |
Total undiscounted cash flows | 11,965 | |
Discount on cash flows | (3,958) | |
Total lease liability | $ 8,007 |
Leases - Weighted Average Term
Leases - Weighted Average Term and Discount Rate (Details) | Sep. 30, 2021 |
Operating | |
Weighted-average term (years) | 17 years 9 months 18 days |
Weighted-average discount rate | 3.52% |
Finance | |
Weighted-average term (years) | 24 years 7 months 6 days |
Weighted-average discount rate | 3.19% |
Reclassification of Comparati_2
Reclassification of Comparative Amounts (Details) | 9 Months Ended |
Sep. 30, 2021USD ($) | |
Reclassification of Comparative Amounts | |
Effect of reclassification adjustment on net income or shareholders' equity | $ 0 |